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I. INTRODUCTION 
A. Cancer 
Cancer has long been a menace and even after decades of 
intense research, much is unknown about this dread disease. 
It has been estimated that one out of every four people in 
the United States will develop cancer, and of these, 68% 
will die from cancer (1). For this reason, massive efforts 
are still directed towards the understanding of this 
disease. 
Cancer is the autonomous growth and reproduction of 
cells. In other words, when a normal cell is transformed 
into a cancer cell, it obtains the ability to determine its 
own activity and retains its ability to produce transformed 
offspring. In the normal cell cycle, there is a block point 
that is used to regulate the initiation of the growth and 
reproductive processes. This block can be removed at the 
appropriate time by the addition of a specific stimulus or 
the removal of inhibitors (2). In a cancer cell, this block 
is either ignored or has been removed. Many researchers 
believe that this arises from a faulty DNA replication 
process that fails to provide the information necessary for 
cell regulation (2,3). Certain compounds have been 
implicated in this "faulty DNA replication process" and are 
known as chemical carcinogens. 
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One class of chemical carcinogens that has received a 
great deal of scientific attention is the polycyclic 
aromatic hydrocarbons (PAH). This interest in PAH as 
chemical carcinogens originated in 1775 when an alarmingly 
high incidence of scrotal cancer was observed in chimney 
sweeps (4). The offending agent was believed to be present 
in the soot to which these workers were continually exposed, 
and was finally isolated and identified as benzo[a]pyrene 
(B[a]P) (5). Since then many other PAH have been implicated 
in chemical carcinogenesis and mutagenesis (6-8). These 
compounds are of great interest since they are produced by 
the pyrolysis or the incomplete combustion of organic 
materials (9), and are, therefore, present virtually 
everywhere (10-12). Some common sources of PAH are 
industrial smoke stacks, motor vehicles, cigarettes, 
fireplaces, and charcoal grills. 
Many researchers believe that the formation of an adduct 
between the genetic material DMA and carcinogens, including 
many of the PAH, is the crucial step in the initiation of 
carcinogenesis (13-15). It is interesting to note, however, 
that B[a]P and many other chemical carcinogens, by 
themselves, are not reactive towards DNA. Instead, they 
must be metabolized to some ultimate carcinogenic form that 
can then bind to DNA (16). Once a carcinogen has been 
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introduced into a cell it has many metabolic pathways it can 
follow. ,, 
As Figure 1 shows, a carcinogen must be metabolized to 
its ultimate carcinogenic form, which can attack the DNA in 
a susceptible cell to produce a "transformed cell." When 
this "transformed cell" reproduces it creates two daughter 
cells with the same defect as the original cell and the 
cancer process is initiated. It should be pointed out that 
there are several paths leading away from cancer. As an 
example, the carcinogen can be metabolized into an inactive 
metabolite that can be removed from the cell as waste. 
Also, many carcinogens are cell-type specific so that even 
in the presence of carcinogens some cells will not develop 
into tumor forming cells (17). Even the transformation of a 
susceptible cell does not guarantee tumor growth due to the 
presence of repair mechanisms that can repair damaged DNA 
(17-19). Also, if the carcinogen binds to the wrong portion 
of the DNA chain it may not affect the growth and 
reproduction of the cell. On the other hand, it could kill 
the cell, terminating the cancer process (17). Complicating 
the matter further, there are synergistic and antagonistic 
effects to take into account, where a second chemical 
compound either helps to facilitate or hinders the formation 
of DNA adducts (15). 
Figure 1. General outline of the metabolic pathways 
available for a carcinogen 
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Truly it is a complicated process that leads from carcinogen 
exposure to cancer. 
B. Metabolic Pathways 
As was pointed out earlier, the important step in this 
process is believed to be the formation of DNA adducts. 
There have been several theories proposed to account for the 
formation of PAH-DNA adducts (20-23). Of these, the most 
widely held is the bay region theory (22). Following the 
hypothesis that many PAHs become carcinogens only after 
metabolic activation, much research was directed towards 
finding the ultimate carcinogenic forms of these PAH. In 
1976, through the efforts of many researchers (24-28), 
strong evidence was obtained indicating that a diol epoxide 
formed from benzo[a]pyrene, trans-7,8-dihydroxy-anti-9,10-
epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE), was an 
important carcinogenic form. This compound is formed, as 
shown in Figure 2, by monooxygenation followed hydrolysis 
and a second monooxygenation step. With this evidence and 
by interpreting substituent effects upon the carcinogenicity 
of benz [a]anthracene derivatives, Jerina and Daly postulated 
that it was the presence of a "bay region" that was the 
critical feature in benzo[a]pyrene and other PAH 
carcinogenesis (22). The prototype of a "bay region" in a 
PAH is the sterically hindered region of phenanthrene. The 
"bay region" of benzo[a]pyrene is indicated in Figure 2. 
Figure 2. The bay region route of metabolism to form the 
diol epoxide of benzo[a]pyrene (22) 
Figure 2 
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Quantum chemical calculations were used to estimate the ease 
of ring opening of the benzylic C-0 epoxide bond to form a 
resonance stabilized carbocation and provided a theoretical 
basis for the bay region theory (29,30). The precise 
mechanism by which diol epoxides react with DNA is as yet 
unknown; however, for benzo[a]pyrene the major adduct is 
believed to occur at the N-2 position of guanine through the 
C-10 position of the benzo [a] pyrene, as shown -in Figure 3 
(31). 
A second metabolic pathway has been proposed, and is 
known as "one electron oxidation" (20,21,32). By this 
mechanism PAH are oxidized to radical cations which can 
react with DNA. A PAH must possess two properties in order 
to be activated via this mechanism. First, in biological 
systems there are agents present that can oxidize compounds 
with an ionization potential less than 7.35 eV; therefore, 
the PAH ionization potential must be less than this to 
become a radical cation. Secondly, the radical cation 
formed must have its charge localized mainly on one carbon 
atom. If the charge is delocalized over many carbon atoms, 
no one carbon atom will possess enough electrophilicity to 
react with DNA (21). Benzo[a]pyrene meets both of these 
requirements and can form a radical cation with the charge 
localized mainly at the C-6 position (33). In vitro studies 
have indicated that this radical cation is indeed formed and 
Figure 3. BPDE-DNA adduct with binding of the B[a]P 
derivative occurring at the C-10 position of 
the diol epoxide to the N-2 exocyclic nitrogen 
of guanine 
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that it reacts mainly with the guanine base in DNA at the 
N-7 and C-8 positions (32). It should be pointed out that 
the adducts formed are unstable resulting in the 
depurination of these adducts (32). Some researchers 
believe that this cleavage of the adducts from the DNA is, 
at least in part, responsible for the initiation of the 
cancer process. 
It is clear from the above discussions that in vivo 
identification of the DNA adducts is necessary to identify 
the metabolic pathways responsible for DNA damage. Detailed 
studies of competing metabolic activation pathways and 
subsequent reactions with DNA bases have been hampered by 
the unavailability of rapid methodologies for determination 
and characterization of the reactive intermediates and 
adducts. The availability of such methodologies would also 
be valuable for the study of DNA repair and synergistic and 
antagonistic effects associated with the components of 
mixtures of carcinogens and mutagens. 
The attributes of an ideal method for the study of DNA . 
damage are outlined here. First, high sensitivity is 
necessary so that the method is applicable to small samples 
of DNA with the low adduction levels found in real samples 
(31). The small DNA sample requirement emerges from the 
fact that one gram of tissue yields 1 mg of DNA and if 
samples from live humans are to be tested only small amounts 
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of tissue will be available. Second, high selectivity is 
necessary to resolve the complex mixtures found in real 
samples. Third, minimal sample preparation, the ability to 
examine intact DNA adducts, and short analysis time are all 
desirable to prevent undetectable changes in the sample 
leading to erroneous results and to facilitate the rapid 
routine analyses of samples. Fourth and last, broad 
applicability is needed for studies involving many different 
types of carcinogens. 
C. Literature Review 
Recent attempts at identifying DNA-PAH adducts have led 
to the development of several analysis techniques. The 
detection of DNA adducts long before clinical symptoms are 
apparent could be the basis for preventative methodologies. 
In Table 1 are listed several current approaches along with 
some figures of merit. 
Of the various immunoassay techniques available for the 
study of DNA damage, enzyme-linked immunosorbent assay 
(ELISA) (13,31,34-38) is the most commonly employed. In 
this method a tailor made antibody, with one or more enzymes 
attached to it, is used to specifically bind to one type of 
DNA adduct. The DNA to be investigated is dried onto the 
walls of a sample well and exposed to the labeled antibody. 
Unreacted antibodies are removed with several washings and 
finally an enzyme substrate is added and allowed to react 
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Table 1. DNA-adduct detection methods (34) 
Technique Analyze Amount of Detection Limit 
DNA (yg) Adducts/base pair 
ELISA intact DNA 50 1/10® 
^^P-Postlabeling base/adduct 5 1/10^^ 
GC/ECD tetrols 500 1/10^° 
GC/MS tetrols 500 1/10^ 
MS/MS base/adduct 500 1/10^ 
Synchronous -, 
Fluorescence tetrols 100 1/10 
HPLC/Fluorescence tetrols 100 1/10^ 
FLNS intact DNA 20 1/10® 
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for a predetermined period of time. The enzyme substrate 
reacts with the enzymes still present in the well to give a 
product whose concentration is easily determined by some 
physical method, e.g., colorimetry. With the knowledge of 
the reaction kinetics, reaction time, initial substrate 
concentration, and amount of DNA present, the damage level 
of the DNA, due to the specific adduct being determined, is 
easily calculated (35). The sensitivity of this method is 
Q 
good as defined by a damage level of ~ 1:10 base pairs for 
~ 50 vg of DNA. Prospects for improved sensitivity are 
centered on the use of even larger amounts of DNA (34). 
ELISA is applied to intact DNA and possesses a superior 
selectivity. However, an antibody must be developed and 
characterized for each and every adduct of interest. 
Furthermore, the immunoassays are likely to encounter 
difficulties for samples derived from cells which have been 
exposed to complex mixtures of genotoxic agents. 
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A second methodology is based on P postlabeling 
(13,31,34,39-43). The use of ^^P postlabeling in the study 
of carcinogenic DNA adducts was first reported by Reddy et 
al. (43). This approach involves denaturation and 
hydrolysis of DNA to nucleoside monophosphates which are 
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subsequently labeled with [ P] phosphate, forming 
nucleoside biphosphates. The adducted along with the 
nonadducted or normal, labeled nucleotides are applied as a 
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spot to a thin layer chromatographic plate. The plate is 
developed in four dimensions, two to remove impurities, 
normal nucleotides, and phosphate groups, and two dimensions 
to resolve different adducts into separate spots on the 
chromatographic plate. Detection is performed autoradio-
graphically. Identification of a spot is accomplished by 
comparing its position on the plate to that of standard 
adducts previously chromatographed. The sensitivity 
attainable is the highest currently available with detection 
limits in the attomole range (~ 1:10^® base pairs for 5 wg 
32 
DNA) possible (41). P-p6stlabeling also has the advantage 
of being generally applicable. The limitations of the 
32 
technique include the use of radioactive P, the limited 
resolving power of thin layer chromatography, and a 20-80 
hour analysis time per sample. 
Gas chromatography with electron-capture detector 
(GC/ECD) and gas chromatography/mass spectrometry (GC/MS) 
are also being applied to DNA damage analysis (13,34,44-46). 
Due to the nature of these techniques the DNA samples must 
be hydrolyzed and derivatized for increased volatility, 
thermal stability, and detectability (44-46). Since only 
the hydrolyzed products are expected to pass through a GC, 
structural information studies of base adducts and nucleo­
tide adducts are not possible (34). To overcome this 
problem soft ionization sputter techniques for the high 
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polarity, thermally and chemically labile modified nucleo­
tides are also being explored as alternate sample introduc­
tion methods for MS analysis, e.g., secondary ion mass 
spectrometry (SIMS) and fast atom bombardment (FAB) 
(13,47-51). However, significant improvements in mass range 
at highest sensitivity are required before soft ionization 
sputter techniques can be adequately exploited (34). The 
circumvention of derivatization is desirable because it is 
time consuming and can lead to uncertainties in 
quantitation. 
Several fluorescence based techniques have also been 
utilized. Synchronous fluorescence spectroscopy (13,31,34, 
52-56), in which the excitation and emission frequencies are 
scanned together to maintain a constant energy or wavelength 
difference between them, takes advantage of the sensitivity 
of fluorescence detection to allow the measurement of a 
O 
single adduct in at least 10 DNA bases, for 100 wg of DNA 
(34). However, the line widths of the measured fluorescence 
bands are too broad to allow the distinction between 
chromophores that have severely overlapped Sq 
absorption origins (31). In a second approach, which relies 
on fluorescence detection (31,34,57-60), DNA adducts are 
hydrolyzed to release the carcinogen moiety (in the case of 
benzo[a]pyrene, as free tetrols), and these are then 
extracted from the residual DNA and separated by high 
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performance liquid chromatography (HPLC). A modification 
level of ~ 1 adduct in 10® DNA bases, for a DNA sample of 
100 ug, has been detected (34). 
A final fluorescence based approach which affords high 
selectivity and can be applied to intact DNA adducts is 
fluorescence line narrowing spectrometry (FLNS) (61). Using 
this method, carcinogenic metabolites and/or DNA adducts are 
directly incorporated into a low temperature amorphous host. 
These matrices can be widely varied in composition in order 
to solubilize most any sample. Analyses are accomplished by 
exciting the low temperature (< 30 K) samples with a spec­
trally narrow line source, e.g., laser, and detecting the 
fluorescence. The fluorescence emitted, unlike room temper­
ature fluorescence, is a pattern of spectrally narrow lines 
characteristic of the chromophore being excited and thus 
acts as an identifying "fingerprint." The fact that differ­
ent chromophores yield different patterns and that the lines 
in these patterns are very narrow gives FLNS its high selec­
tivity. It is the intent of this dissertation to show that 
FLNS is a rapid, broadly applicable, sensitive, and selec­
tive technique for the study of chemical carcinogenesis. 
D. Theory: Principles of FLNS 
The theory of FLNS has previously been discussed in 
great detail (62-65); therefore, only a brief discussion 
will be given here. 
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A solution containing PAH at room temperature possesses 
a broad absorption prpfile. Excitation of this solution 
yields an equally broad fluorescence profile. If, however, 
this solution were frozen to a low temperature (< 30 K) 
amorphous solid (glass), the homogeneous absorption line-
widths for the individual PAH would be reduced. However, 
glasses are structurally disordered and therefore each 
molecule would occupy an energetically inequivalent site 
(62-65). Since the + Sg transition energy of a molecule 
is influenced by its environment, a distribution of narrow 
homogeneous absorption bands is formed and again yields a 
broad absorption profile known as a site inhomogeneously 
broadened absorption profile (62-65). 
FLN is a site excitation energy (isochromat) selective 
spectroscopy which can eliminate or significantly reduce the 
contribution of site inhomogeneous line broadening, r^, to 
spectral profiles (62-65). A site inhomogeneously broadened 
absorption profile is depicted in Figure 4 and is the 
convolution of a very large number of individual site 
absorptions possessing a homogeneous linewidth r. At liquid 
helium temperatures r ^ 0.1 cm ^, while for amorphous 
molecular hosts such as glasses or polymers ~ 300-500 
cm Classical broad band excitation of all the 
energetically inequivalent sites which contribute to the 
profile of Figure 4 results in an equally broad fluorescence 
Figure 4. Low temperature absorption profile of a solute 
in an amorphous solid. The inhomogeneous and 
homogeneous bandwidths (r ^  and r) are 
indicated 
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spectrum. Such spectral resolution does not allow for the 
distinction between substitutional isomers of a given PAH 
(for example) since their states typically lie within 
several tens of cm~^ from each other. However, selection of 
a narrow isochromat of the absorption profile with a laser 
of width Av << Tj can result in dramatic line narrowing 
provided certain conditions are met. First, the impurity 
concentration must be sufficiently low to preclude site 
randomization due to intermolecular energy transfer on a 
time scale comparable to the excited state lifetime. In 
addition, the fluorescence observed must originate from the 
electronic state being excited — a consequence of the fact 
that site energy distribution functions for different 
electronic states are generally not correlated. Thus, the 
narrow isochromat of the state selected by the laser maps 
onto a much broader "polychromat" in another excited 
electronic state. 
For practical applications of FLN on molecular systems, 
the origin or low lying vibronic transitions of the lowest 
excited singlet (S^) state are generally excited. For 
origin excitation, the resonance fluorescence (origin) 
transition occurs at the laser frequency and is, therefore, 
not a reliable analytical line. Furthermore, the vibronic 
transitions provide only the ground state vibrational 
frequencies. Utilization of vibronic excitation is 
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significantly better from the standpoints of 
characterization and selectivity. Figure 5 depicts an 
absorption spectrum in which there are two overlapping 
vibronic transitions to fundamental excited state vibrations 
l(j and Ig. To the left is an energy level diagram in which 
the slanted parallel lines indicate the site inhomogeneous 
broadening for the (1^,0) and (1^,0) transitions. The laser 
excitation frequency is chosen to excite different 
isochromats belonging to the v^ = 1 and Vg = 1 levels. For 
example, selects an isochromat associated with Vg = 1 
that lies near the bottom of its distribution while that 
associated with v^ = 1 lies near the top of its 
distribution. As vibrational relaxation occurs on the 
picosecond timescale, it precedes the fluorescence which 
originates from the zero-point vibrational level. 
Vibrational relaxation is indicated by the downward wiggly 
arrows which show that fluorescence originates from two 
different isochromats that are linked to the two vibrations 
initially excited. The resulting fluorescence spectrum has 
the appearance of Figure 5b in which the laser line (u)^) 
lies to higher energy of all fluorescence bands. 
Fluorescence from the two isochromats results in a doubling 
of the origin or (0,0.) transition as well as the (0,1) 
vibronic transitions. An important point is that the 
displacements between and the (0,0) bands provide the 
Figure 5. Schematic representation of laser site 
selection in FLNS (see explanation in text) 
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excited state vibrational frequencies (w' and w') while the 
ot p 
displacements between the (0,0) and (0,1) bands yield ground 
state vibrational frequencies. 
It should be pointed out that the sensitivity of FLN is 
approximately the same for either origin or vibronic 
excitation. For the PAH the vibronic Franck-Condon factors 
in absorption are typically smaller than origin Franck-
Condon factors, but this is compensated for by the fact that 
the fluorescence origin transition is a useful analytical 
line in spectra generated with vibronic excitation. Figure 
5. In addition, by varying in the vibronic excitation 
mode it is possible to explore a wide range (~ 400-1300 
cm ^) of excited state vibrational frequencies. Thus, a 
greater degree of characterization and minimization of 
spectral interference is possible. 
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II. EXPERIMENTAL 
À. Materials and Reagents 
The tubes used as sample holders changed as the 
experimental apparatus and design evolved. Initially 
polystyrene (Falcon) tubes, 12 x 75 mm, were used. These 
were followed by quartz melting point tubes (ISU glass shop) 
open at both ends and mounted horizontally using surface 
tension to hold the sample in place. The final and best 
sample container is a 2 mm i.d. quartz tube (ISU glass shop) 
sealed at one end and held in a vertical position. For some 
experiments anaerobic sample conditions were needed. To 
accomplish this samples were exposed to a series of five 
freeze/pump/thaw cycles prior to completely sealing the tube 
under anaerobic conditions. Typical sample volumes were .5 
ml, 50 pi, and 30 ^1, respectively, for each of the sample 
tubes. The smaller sample volume was desirable to achieve 
lower detection limits as discussed in the instrumental part 
of this section. Quartz tubes were necessary for the 
ultraviolet excitation and emission wavelengths typically 
encountered with the species investigated. Samples 
discussed in this dissertation were not degassed unless so 
indicated. 
The solvents used were from different commercial 
sources. Reagent grade glycerol from Fisher Scientific 
Company was used without further purification. The 95% 
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ethanol was obtained from the university storeroom. Water 
was drawn from the laboratory distilled water supply. 
Reagent grade dimethylsulfoxide (DMSO) was obtained from 
Alltech Associates and used without further purification. 
Several glass formulations were used depending on the 
sample being investigated. Most of the samples investigated 
were diluted into a 45% glycerol, 35% water, and 20% ethanol 
(by volume) mixture. This mixture forms an optically trans­
parent glass at low temperatures (66). For some experiments 
a pure water host or a 90% water/10% DMSO mixture was used. 
The DMSO was found necessary to solubilize some samples. 
Although neither of these formed an uncracked low 
temperature glass, they were suitable for viewing relatively 
long lived fluorescent species (> 10 nsec) when a gated 
detection system was employed to eliminate laser scatter. 
Many samples were used for this research. Sample names, 
acronyms (to be used throughout the rest of this 
dissertation), suppliers, and how they were prepared if 
deemed necesary, are listed according to type: metabolites, 
DNA adducts, nucleoside adducts, globin adducts, and test 
compounds used to determine the sensitivity of the 
instrumentation. 
The metabolites consisted of 1,2,3,4-tetrahydro-l,2,3,4-
tetrahydroxybenz [a]anthracene (B[a]AT-l); 8,9,10,11-
tetrahydro-8,9,10,11-tetrahydrobenz[a]anthracene (B [a]AT-8); 
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1,2,3,4-tetrahydro-l ,2,3, 4-tetrahydroxy-5-rtiethylchrysene 
(5-MeCT); 1,2,3,4-tetrahydro-l,2,3,4-tetrahydroxychrysene 
(CT); 4,5-dihydro-4,5-dihydroxy-9-methoxybenzo[a]pyrene 
(B [a]P-diol); 7,8,9,lO-tetrahydro-7,8,9,10-tetrahydroxy-
benzo[a]pyrene (B[a]PT); 7,8,9,lO-tetrahydro-8,9,10-
trihydro-7-hydroxybenzo[a]pyrene (7-HTHB[a]P); 7,8,9,10-
tetrahydro-7,8,9-trihydro-lO-hydroxybenzo[a]P (10-HTHB[a]P); 
7,8,9.10-tetrahydro-l,8,9.lO-tetrahydrobenzo[a]pyrene 
(THB[a]P); 6-methylbenzo[a]pyrene (6-MeB[a]P); and 
benzo[a]pyrene (B[a]P). B[a]AT-l, B[a]AT-8, CT and B[a]PT 
were obtained from the Midwest Research Institute, Kansas 
City, Missouri, through the NCI depository. The 5-MeCT was 
supplied by S. S. Hecht and A. Melikian, Naylor Dana 
Institute for Disease Prevention. The B[a]P-diol, 
7-HTHB[a]P, 10-HTHB[a]P, and THB[a]P were supplied by R. G. 
Harvey, Ben May Laboratory for Cancer Research, University 
of Chicago, Chicago, Illinois. The 6-MeB[a]P and B[a]P were 
obtained from E. Cavalieri and E. Rogan, Eppley Institute 
for Research in Cancer, University of Nebraska Medical 
Center, Omaha, Nebraska. All the above listed samples were 
used without further purification and are shown in Figure 6. 
Most of the DNA adducts were made by exposing DNA to the 
epoxide derivatives of 5-MeCT, CT, B[a]AT-l, B[a]AT-8, and 
B[a]PT. The structures of these adducts are shown in Figure 
7 along with their acronyms derived from the diol epoxide 
Figure 6. Acronyms and structures of PAH 
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Figure 6 
BCa]AT-l BCa]AT-8 
R=CH gS-MeCT 
R=H CT 
UeO 
OH 
BCa]P-diol BC a] PT 
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S-MeBCoJP 
lO-HTHBCa] P 
THBColP 
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Figure 7. Structures of five DNA adducts. The acronyms 
for adducts I-V are, respectively, 
5-MeCDE-DNA, CDE-DNA, BPDE-DNA, B[a]ADE-8-DNA, 
and B[a]ADE-l-DNA 
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metabolite involved. Samples of trans-3,4-dihydroxy-anti-
1,2-epoxy-l,2,3,4-tetrahydrobenz[a]anthracene (B[a]ADE-1); 
trans-8,9-dihydrodiol-anti-lO,ll-epoxy-8,9,10,11-tetra-
hydrobena[a]anthracene (B[a]ADE-8); trans-1-2,-dihydroxy-
anti-3,4-epoxy-l,2,3,4-tetrahydrochrysene (CDE); and trans-
7,8-dihydroxy-anti-9,lO-epoxy-7,8,9,10-tetrahydrobenzo[a]-
pyrene (BPDE) were obtained from the NCI Carcinogen Standard 
Reference Repository and were used directly. Trans-1,2-
dihydroxy-anti-3,4-epoxy-l,2,3,4-tetrahydro-5-methylchrysene 
(5-MeCDE) was provided by S. S. Hecht. Calf thymus DNA was 
obtained from Sigma Chemical Company and repurified by 
phenol extraction and ethanol precipitation prior to use. 
DNA (2 mg in 4 mL of 10 mM cacodyate buffer pH 7.0) was 
modified by the addition of the appropriate diol epoxide (2 
mg dissolved in 150 uL of tetrahydrofuran followed by 3.85 
mL of acetone). After reaction for 4 hours, the solution 
was extracted 4 times with ethyl acetate and, after the 
addition of 200 uL of 2 M sodium at pH 5.4, the DNA was 
precipitated 3 times with 2 volumes of ethanol. The 
modified DNA was enzymatically digested to monodeoxy-
ribonucleoside derivatives (67) and the modified 
deoxyribonucleoside derivatives separated by HPLC. The HPLC 
separations were obtained with an 850 system (Du Pont, 
Wilmington, Delaware) with an exponential gradient from 30 
to 60% methanol in water over 90 min and at 50°C on a Waters 
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Associates (Milford, Massachusetts) yBondapak C-18 column. 
Samples were detected by their absorption at 254 nm. The 
extent of modification of adduct III in Figure 7 was 
determined by the Randerath procedure (39,40) and was 0.4%. 
DNA samples digested after treatment with the 
8,9-diol-lO,11-epoxide of benz [a]anthracene or the chrysene 
diol epoxide each gave one major adduct, while that from the 
3,4-diol-l,2-epoxide of benz[a]anthracene gave two major 
adducts in a 3.4:1 ratio. Samples were collected from the 
HPLC procedure and the solvents removed by evaporation under 
reduced pressure. The Randerath procedure was not used to 
determine the modification levels of adducts II, IV, and V 
in Figure 7 since UV absorption measurements showed that 
they are comparable to that of adduct III, vide supra. 
The low modification level, 5:10^ and 8:10^ 
(adducts;base pairs), DNA adducts of benzo[a]pyrene were 
obtained from lOTl/2 cell cultures treated with [^H]-benzo-
[alpyrene (1-0.004 mg/mL) for 24 hours. [^H]-benzo[a]pyrene 
was obtained from Amersham Searle, Arlington Heights, 
Illinois. Other chemicals were commercially available from 
standard sources. The cells were grown as previously 
described in ref. 67 and after treatment with the [^H]-
benzo[a]pyrene the cells were washed with PBS and scraped 
from the plates. The DNA was extracted using methods 
similar to those described in ref. 67. The nuclei, isolated 
by disruption of the cytoplasmic membrane by Triton X-100, 
were solublized with a 1% SDS solution at pH 6.9, containing 
15 mM NaCl and 1.5 mM citrate. This solution was then 
extracted several times with water-saturated phenol before 
the DNA was precipitated from the aqueous phase with two 
volumes of ethanol. The DNA was redissolved and treated 
with RNase before reextraction with phenol and two ethanol 
precipitations. The modification levels of these adducts 
were also determined by the Randerath procedure. All DNA 
adducts, listed to this point, were made by A. Jeffrey, 
Institute for Cancer Research, Columbia University, New 
York, New York. 
For studies concerning "one-electron oxidation," the DNA 
adducts were prepared by exposing DNA to B[a]P in the 
presence of horseradish peroxidase (HRP) and HgOg, followed 
by a cleanup procedure (32). These samples shall be 
referred to as HRP-DNA, and were supplied by E. Cavalieri 
and E. Rogan, Eppley Institute for Cancer Research, 
University of Nebraska Medical Center, Omaha, Nebraska. 
Fish DNA from live fish exposed through controlled 
environmental conditions to dibenz[a,h]anthracene, benzo[b]-
fluoranthene, and benzo[a]pyrene was supplied by U. 
Varanesi, National Marine Fisheries, Seattle, Washington. 
Samples of DNA base adducts of B[a]P (bound at the 6 
position) attached at the C-8 positions of guanosine. 
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deoxyguanosine, and guanine, and at the N-7 position of 
guanine will be referred to as B[a]P-C-8G, B[a]P-C-8dG, 
B [a]P-C-8gua, and B[a]P-N-7gua, respectively (see Figure 8). 
These samples were electrochemically synthesized by 
selective anodic oxidation of B[a]P in the presence of the 
nucleoside (32). The pure product was obtained by 
extraction followed by HPLC or TLC and subsequently by HPLC 
depending on the adduct desired. These samples were also 
supplied by E. Cavalieri and E. Rogan. 
Globin adduct samples were supplied by R. Santella, 
Institute for Cancer Research, Columbia University, New 
York, New York, and were prepared as previously described in 
ref. 68. 
Urine samples used in this research were donated by R. 
Jankowiak, D. Zamzow, or the author. 
Test compounds used to optimize and test the 
instrumentation were anthracene and 6-methylpyrene. These 
samples were obtained from Aldrich and API, respectively, 
and used without further purification. 
B. Sample Preparation 
Samples were prepared for analysis in the following 
manner. Samples of metabolites and nucleoside adducts were 
diluted in the desired glass matrix to a known concentration 
(£ 10 ^ M) of the chromophore to be observed. DNA adducts 
were dissolved in water to a DNA concentration of ~ 1 mg/mL. 
Figure 8. Structures and acronyms of nucleoside adducts 
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The low modification level DNA adducts were observed in this 
condition. The higher modification level samples (> 1:10^) 
were diluted with the glycerol/ethanol/water glass 
formulation to make these samples ^  10~^ M in adduct 
concentration. The sample (~ 30 pL) was placed into a 
sample tube. Only the 2 mm i.d. quartz tube arrangement 
will be considered since it is superior to earlier sample 
containing arrangements. The sample tube is held vertically 
in an aluminum sample holder designed to occlude scattered 
laser radiation originating from the sides of the sample 
tube. This sample holder is attached to the bottom of a 
long rod and lowered into an optical helium dewar to attain 
low sample temperatures. Two different dewars were used 
depending on what sample temperature was desired. If only 
4.2 K was needed, a 3 L double nested glass total immersion 
liquid helium dewar manufactured by Pope Scientific was 
used. The dewar is constructed so that no liquid nitrogen 
is in the optical pathway in order to eliminate scattering 
from nitrogen bubbles. The dewar is equipped with quartz 
windows so that ultraviolet excitation could be employed. 
For studies that required sample temperatures other than 4.2 
K, a Janis Research model 8-DT Super Vari-Temp liquid helium 
immersion cryostat equipped with an optical access tail 
section was utilized. Sample temperatures were measured 
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using a silicon diode thermometer (Lake Shore Cryogenics 
model DT-500K) calibrated over the range 1.4 K to 300 K. 
C. Instrumentation 
To perform fluorescence line narrowing spectrometry some 
minimum amount of equipment is necessary. The equipment 
needed can be divided into four major components: a 
spectrally narrow excitation source, an optically accessible 
low temperature sample chamber, a dispersion device, and a 
detection system. The first two components are necessary 
for the FLN phenomenon to occur, as discussed in the 
introduction, and the last two components are needed to 
disperse and detect the emitted fluorescence. Since the 
sample chamber was discussed in part B of this section only 
the other three components will be considered. This 
discussion presents the development of the FLN 
instrumentation from the initial prototype (69) to its 
present state shown in Figure 9. The discussion is divided 
into three parts; excitation, fluorescence collection, and 
detection. Each part will detail how and why the 
instrumentation evolved. 
Originally two excitation sources were used, a nitrogen 
laser pumped dye laser system and a Nd-YAG laser pumped dye 
laser system. The first consisted of a Molectron UV-14 
nitrogen laser capable of ~2 mJ/pulse operated at a 
repetition rate of 30 Hz. This laser emitted radiation at 
Figure 9. Block diagram of present FLNS instrumentation 
showing excimer laser (Exc. L), dye laser (Dye 
L), cryostat (C), sample (S), photodiode (PD), 
photodiode array (PDA), monochromator (M), 
optical multichannel analyzer (OMA), and 
printer (P). See text for discussion 
Figure 9 
43 
Trig 
PDA Sync 
PD 
HV DG 
OMA 
Z D C  
Exc. L Dye L 
337 nm which was used to pump a molectron DL-200 dye laser. 
Conversion efficiency of the dye laser was typically ~ 4% 
and, therefore, average excitation powers were less than 2 
mW. Using this dye laser with the Exciton dyes PBD, BBQ, 
PBBO, Bis-MSD, and DPS a spectral range from 357 to 430 nm 
was accessible. This was suitable for most of the 
experiments conducted. For some samples, however, 
wavelengths less than 357 nm were needed. For these cases 
the doubled beam of a Quanta Ray OCR Nd-YAG laser with a 
wavelength of 532 nm was used to pump a Quanta Ray PDL-1 dye 
laser using LDS-698 (Exciton) as a dye. The output of the 
dye laser was then doubled using an Inrad model 5-12 
frequency doubler. This system allowed the coverage from 
322 to 372 nm with average laser powers of 2 mW at 10 Hz. 
Although both of these excitation systems were adequate for 
initial experiments, they had some shortcomings. First, it 
is not desirable to have to use two laser systems. A less 
complex setup would have one laser to cover all spectral 
regions of interest. Secondly, neither laser system had 
sufficient peak powers to fully excite the sample and, 
therefore, did not yield all the fluorescence possible. As 
a result, the lowest limit of detection was not obtained. 
Other problems with the nitrogen laser system arose from the 
fact that the dye laser emitted a large amount of amplified 
spontaneous emission and, therefore, only the low energy 
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sides of dyes were desirable to use. Lastly, the Nd-YAG 
system could only be operated at.10 Hz. A better 
arrangement would include high repetition rates to decrease 
the amount of time needed to acquire a spectrum. To 
circumvent these problems, a new laser excitation system was 
obtained. 
The new system consists of two basic parts, an excimer 
laser and a dye laser. The excimer laser is a Lambda Physik 
EMG 102 MSG excimer laser equipped with an Intelligent Laser 
Control (ILC). For this research the laser was used with Xe 
and HCl gases forming the excimer XeCl under a high voltage 
discharge with He acting as the buffer gas. With these 
gases, the laser is capable of delivering up to 150 
mJ/pulse, when higher pulse energies are needed the buffer 
gas can be replaced with Ne gas to yield up to 210 mJ/pulse. 
The output has a temporal width of ~ 10 nsec and can be 
operated up to 100 Hz. This laser has a synchronous 
electronic output pulse that is synchronized to the firing 
of the laser. Unfortunately, the actual laser firing can 
slowly drift with time and thyratron temperature relative to 
the electronic synchronous output pulse. For gated 
detection experiments this was unacceptable and, therefore, 
a device known as a Zero Drift Control (ZDC) manufactured by 
Lambda Physik (model EMG 97) was used to compensate for this 
drift. The ZDC uses a photodiode output pulse and the 
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electronic synchronous output pulse and introduces them into 
an electronic comparator which corrects for the long term 
temporal drift. This ZDC outputs a new "truly" synchronized 
output pulse. After eliminating this long term drift, the 
system is left with the shot to shot instability of the 
thyratron. This instability is about ± 7 nsec, making a 7 
nsec delay necessary to completely eliminate laser scatter 
detection. This 7 nsec delay is much better than the 
necessary long delays employed previously. 
The actual operation of the laser, aside from the 
timing, is accomplished through the ILC. This device 
monitors the number of shots fired, thyrotron voltage, 
output energy, and repetition rate. It will also execute 
partial and full laser cavity gas refills, when necessary, 
in order to maintain a constant preset energy level. 
Probably the most important feature of the ILC is its 
ability to use comparative feedback from an output energy 
monitor to maintain a constant energy output. 
The beam emerging from the excimer laser is used to pump 
a Lambda Physik FL 2002 dye laser system. This system is 
composed of three parts: the dye laser, the scan 
controller, and a removable étalon. The dye laser is of a 
Littrow geometry using a grazing incidence grating for 
wavelength selection. Two dye cells are included in this 
laser. The first acts as both an oscillator and a 
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preamplifier. The second acts as an amplifier, all are side 
pumped. This system yields a 0.22 cm~^ spectral linewidth 
which can be reduced to 0.04 cm~^ by inserting the étalon. 
The dye laser is controlled by a Lambda Physik FL 512A scan 
controller, which will control both the grating and the 
étalon. The scan controller is also equipped to accept 
external control from a computer. Using this dye laser 
system, wavelengths from 332 to 985 nm are available through 
the use of several laser dyes and XeCl as the excimer 
emission source. If KrF is used instead of XeCl and 
BM-terphenyl (Lambda Physik) is used as the dye laser dye, 
wavelengths down to 312 nm are accessible. 
The output beam of the dye laser is shaped as a 
symmetrical trapezoid with approximate dimensions of 2 mm by 
3 mm. To fully utilize this beam when exciting the sample 
(cross section 2 mm x 10 mm), it is necessary to form the 
beam to the shape of the sample. This is accomplished using 
two quartz 90° turning prisms to direct the beam into the 
proper pathway, and two lenses, one quartz biconvex and one 
quartz plano-convex cylindrical lens to form the beam such 
that its cross sectional dimensions at the sample are as 
those of the sample to insure complete irradiation. 
Following irradiation of the sample, the fluorescence is 
collected and dispersed. The collection is accomplished 
with two lenses and the dispersion is produced in a grating 
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monochromator. The original FLN setup used two 1 inch 
diameter quartz lenses for collection, one to match the 
f/5.3 monochromator and the other to collect and collimate. 
At that time, a narrow laser beam intersecting the sample 
was used to create a horizontal line of fluorescence in the 
sample (69). The monochromator was mounted on its side to 
have a horizontal entrance slit in order to accommodate the 
horizontal image. A problem arose when the new higher 
resolution monochromator was obtained since it had vertical 
slits and can not easily be mounted sideways. To overcome 
this problem, a dove prism (Melles Griot) was mounted 
between the two collection lenses in order to rotate the 
image by 90° as discussed in ref. 70. When the sample tube 
arrangement was changed to accommodate smaller sample 
volumes and beam formation was employed a vertical image was 
formed, therefore the dove prism was no longer necessary. 
An important consideration in low level fluorescence 
detection is capturing as much fluorescence as possible and 
introducing it into the monochromator. There are two things 
to keep in mind when approaching this problem. First, one 
must match the f number of the monochromator. If the 
monochromator grating is over-filled, light is lost and 
stray light is introduced inside the monochromator, not a 
desirable situation from a signal to noise standpoint. On 
the other hand, if the grating is under-filled, resolution 
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is lost. Secondly, one must keep in mind that there is a 
tradeoff between the amoynt of light collected and the 
amount that enters the monochromator. This tradeoff is 
summed up in Figure 10 and Equations 1-5. 
Equation 1 is the basic lens equation relating focal 
3 - X + y (1) 
length (f), object distance (y), and image distance (x). By 
setting the diameter of the lens (d) equal to x/7, matching 
of the lens to an f/7 monochromator is insured. Equation 2 
C = = -âl = (Mill . (2) 
4ny^ 16y^ 16y 784y^ 
yields the fraction of total fluorescence collected (C). 
Equation 3 determines the magnification of the image (m) and 
m = ^ (3) 
Equations 4 and 5 calculated the percent of the height (H) 
and the width (W) of the image that is passed by the slit. 
Figure 10. Collection optics diagram. Dimensions are 
height x width. See explanation in text 
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By multiplying equations 2, 4, and 5 together and using the 
appropriate boundary conditions, a maximum can be calculated 
which corresponds to the maximum percentage of light that 
can be collected and introduced into the monochromator. For 
the present system a f/3.5 lens placed midway between an f/7 
monochromator and fluorescent source separated by 14 times 
the diameter of the lens would give optimum results. Due to 
space constraints, two 50 mm diameter lenses, one to collect 
and collimate and the second to match the monochromator, 
were used to mimic the one lens system described above. 
Using the earlier equations an overall collection efficiency 
of 0.02% was calculated for the system and conditions used. 
This does not take into account losses at the dewar window 
and lens interfaces. Also, the actual amount of 
fluorescence collected was between 1 and 2 times the 
calculated value since the inside of the aluminum sample 
holder acts as a back reflector. From the equations 
presented above, one can see that a reduced sample size 
without a reduction in the number of fluorescing molecules 
will allow a greater amount of fluorescence to be passed by 
the entrance slit. For this reason, smaller sample tubes 
and higher concentration samples were employed to lower the 
limit of detection, as mentioned earlier. The collected 
fluorescence was originally dispersed by a 0.3 meter (f/5.3) 
McPherson monochromator (model 218). This device had a 
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linear dispersion of 2.65 nm/mm yielding a resolution of 
0.06 nm at entrance and exit slit widths of 10 w. When it 
was determined that higher resolutions would be needed for 
the experiments planned, a 1 meter (f/7) McPherson scanning 
monochromator (model no. 2061) of the Czerny Turner geometry 
was obtained. This instrument is equipped with a, 136 mm 
ruled width x 116 mm groove length, snap-in grating with 
2400 grooves/mm and has a transmission range of 185 nm to 
650 nm. This system yields a linear dispersion of 0.416 
nm/mm and a resolution of 0.005 nm using 7 u slit widths. 
The monochromator is scanned by a McPherson (model 788) 
Digital Drive Control System equipped with an RS 232 
computer interface port. One additional feature worth 
noting is a second detector mount accessed by merely turning 
a mirror into place, making a switch between two detectors 
trivial. Before moving on to the detection system, sample 
alignment should be discussed. Since some of the 
experiments performed dealt with very low levels of 
fluorescence, great care had to be taken in the alignment 
procedure. For optimum alignment a detector was removed and 
the monochromator is set to zero order. An attenuated HeNe 
laser beam was directed through the monochromator and 
collection optics. At the same time, the dye laser 
(excitation) beam was made to cross the HeNe beam exactly at 
the focal point of the first collection lens. The sample 
54 
inside the dewar was then positioned at the intersection of 
these beams insuring optimum alignment. The HeNe could then 
be removed and the detector replaced. 
The original detector employed was an Amperex XP-2232 
photomultiplier tube (PMT) specially wired for fast 
response (71). Signals from the PMT were electronically 
divided by signals from a UDT-UV 20 (Universal Detector 
Technologies) reference photodiode monitoring the laser 
beam intensity, in order to cancel out pulse to pulse 
variations from the laser. The signals were ratioed via a 
Quanta Ray DGA-1 dual-gated amplifier with a gate time of 
100 usee and an internal delay of 100 nsec or an EG&G Parr 
model 162 boxcar averager equipped with two model 164 gated 
integrators and an adjustable internal delay and gate 
window. Since the synchronous output pulses from all of the 
lasers used comes before and within 100 \i sees of the light 
pulses, neither of the signal processors had a problem 
monitoring the fluorescence. Emission spectra were obtained 
by scanning the monochromator over the desired wavelength 
region and using the ratioed output from either device to 
drive the pen on a Heath chart recorder (model SR-204). 
Spectra were taken in real time. After the acquisition of 
the McPherson 1 meter monochromator with two detector ports, 
a second detection system was added. This second system 
consists of a Tracor Northern (TN 6134) blue-enhanced 
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intensified gateable photodiode array (PDA) and a Tracor 
Northern (TN 6500) optical multichannel analyzer (OMA). The 
diode array consists of 1024 diodes (25 n x 2.5 mm) covering 
~ 26 mm with an active area of ~ 18 mm. This detector in 
conjunction with the 1 meter monochromator allows the 
simultaneous acquisition of ~ 6 nm. Gating is accomplished 
by the rapid switching of the microchannel plate 
intensifier. Gate widths from 5 to 120 nsec are available 
using an Avtech (model AVL-TN-1) high voltage switch. The 
resolution of the diode array is 4 channels FWHM making the 
diode array appear to be a 100 u exit slit. Using a 100 u 
entrance slit, the optimum resolution was ~ 0.04 nm. If 
higher resolution is needed, use of the PMT is necessary. 
One of the most important features of the PDA system is the 
gatability. This allows for the discrimination between 
scattered laser light and low levels of fluorescence and the 
temporal resolution of species with differing fluorescent 
lifetimes. Gating is accomplished by using the synchronous 
output from the ZDC occurring ~ 10 usee before the laser 
pulse. This output pulse is fed into a Berkeley Nucleonic 
Corporation (model 8010) pulse generator (acting as a delay 
generator) and delayed so that its output triggers an Avtech 
high voltage switch to turn the detector microchannel plate 
on nanoseconds after the laser pulse arrives at the sample. 
Typically the time difference between the laser scatter 
arriving at the detector and the detector being activated is 
20 nsec. The actual setting of this delay was accomplished 
by tuning the monochromator to the laser wavelength, setting 
the detectors temporal gate width to 5 nsec and the detector 
integration time to some short time period (~ .1 sec), and 
adjusting the delay until the signal on the OMA screen is 
maximized. This corresponds to a 0 nsec delay. To 
accurately set the delay to some delay other than 0 nsec, a 
tap from the high voltage switch is monitored relative to 
the synchronous output pulse from the ZDC on a Tektronix 
(model 2213) oscilloscope, as the delay is changed with the 
delay generator. Once the desired delay is set the gate 
width can be opened. The actual acquisition of a spectrum 
is a two step process. First, a background spectrum is 
taken (without the sample being irradiated). Then a 
fluorescence spectrum is taken. The background is 
subtracted automatically, via the OMA, to account for the 
varying individual diode responses and to remove any 
background light admitted to the detector. There are two 
parameters to adjust when taking a spectrum, integration 
time per scan and scans per spectrum. Since the signal to 
noise ratio increases more rapidly as a function of 
increasing integration time than as a function of the number 
of scans, the best situation is to use the longest 
integration time possible with a large number of scans. 
57 
Typically, for the experiments performed, the detector 
begins to saturate at detection times greater than 15 
seconds. For this reason, most spectra were obtained with 
an integration time of 10 sec for 10 scans, making a 
complete spectrum possible in 200 sec. The PDA is also 
equipped with a peltier cooler and is cooled to -20°C to 
reduce dark noise. The OMA itself is a multifunctional data 
processing system that allows automatic background 
subtraction, mathematical data processing, histogram data 
acquisition, magnetic disk data storage and a whole host of 
other options. A hard copy of data is obtained by output to 
either a Hewlett-Packard Think Jet printer or a 
Hewlett-Packard (HP 7470A) dual pen plotter. 
For those experiments performed requiring white light 
restoration pulses, a tungsten-halogen lamp (General 
Electric) was used as the light source to irradiate the 
sample via a third window in the sample dewar. In order to 
prevent this light from reaching the gated detector when it 
was activated, a Uniblitz high speed shutter (Vincent 
Associates) was employed. This shutter was activated by the 
ZDC and delayed such that the shutter was opened 1 msec , 
after the laser light pulse for 1 msec. 
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III. RESULTS AND DISCUSSION 
A. Introduction 
FLN spectrometry has demonstrated the ability to 
identify amino PAH (72) and to analyze for nonpolar PAH in 
both laboratory mixtures and a solvent-refined coal sample 
(63,73). More recently, it was shown that FLN spectrometry 
was applicable to active metabolites of B[a]P and the 
adducts they form with DNA (61). In addition, a mixture of 
two B[a]P metabolites was analyzed using FLN. These results 
demonstrated that FLN spectrometry in glasses has exciting 
potential for the direct high-resolution analysis of nucleic 
acid damage resulting from chemical carcinogens. 
Several important questions, however, were left 
unanswered by this prior research. One relates to the 
generality of FLN spectrometry. That is, can FLN 
spectrometry generally be applied to the polar metabolites 
of PAHs and the DNA adducts and other biologically important 
adducts? Furthermore, does FLN spectrometry possess the 
selectivity to identify the PAH metabolite and adduct 
components of reasonably complex mixtures? This will be 
important if the synergistic and antagonistic effects on DNA 
damage are to be studied in the future. Finally, does FLN 
spectrometry possess the sensitivity to detect DNA damage at 
the low levels required for practical applications to real 
samples? The intent of this dissertation is to explore 
59 
these questions. To this end, the results of FLN studies on 
a six metabolite mixture, a five component intact DNA adduct 
mixture, and finally an eight component mixture of both 
metabolites and DNA adducts are presented and discussed to 
establish the selectivity of FLN for these types of species 
(70,74). Following this is a discussion of the measures 
required to achieve a femtomole limit of detection for the 
BPDE-DNA adduct and the steps that had to be taken in order 
to retain the high selectivity of the FLN method when using 
the high laser excitation power densities needed to obtain 
this limit of detection (75). Lastly, the application of 
FLN to the investigation of BPDE-globin adducts, metabolites 
in urine, real samples, and metabolic pathways is presented 
to demonstrate the broad applicability of FLN spectrometry 
(75). 
B. Selectivity 
As a first test of the selectivity of the FLN method, 
the resolution of a mixture of six polar PAH metabolites, 
B[a]AT-l, B[a]AT-8, 5-MeCT, CT, B[a]P diol, and B[a]PT 
(shown in Figure 6), was attempted (70). The underlying 
physics of the FLN phenomenon were described in the 
introduction. There it was shown that excitation into the 
origin (0,0) band of the fluorescent state with a narrow-
line laser selects out a comparably narrow isochromat, and 
the fluorescence spectrum is narrowed. It was also shown 
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that excitation into low-lying vibronic bands, (1,0) 
excitation, also yields FLN. For many molecules, a 
low-lying (1,0). absorption band several hundred inverse 
centimeters above the (0,0) band which is due to a single 
vibration can be found. Excitation of such a (1,0) band 
affords a FLN spectrum which matches in simplicity the 
spectrum obtained with (0,0) excitation. However, for (1,0) 
excitation, the origin or (0,0) fluorescence band is 
displaced to lower energy of the laser frequency by an 
amount equal to the frequency of the excited vibration. 
This is important because the (0,0) fluorescence band is now 
a useful analytical line. For (0,0) excitation, the 
fluorescence origin is typically contaminated by laser light 
scatter. The complexity which arises when the vibronic 
absorption feature being pumped is comprised of several 
overlapping and unresolvable (1,0) bands has been considered 
(63). Laser excitation of such a vibrationally congested 
feature pumps as many different isochromats as there are 
overlapping bands. In the extreme, where the number of 
bands is very large, line narrowing is lost and the 
fluorescence spectrum has the broad and disappointing 
appearance of the spectrum obtained with a broad-band 
excitation source which uniformly excites all sites. 
Importantly, however, when the number of bands is small (~ 
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3), the analytical utility of FLN spectrometry is enhanced 
when (1,0) rather than (0,0) excitation is utilized... 
Fluorescence excitation spectra, not given here, were 
used as a guide for the determination of several suitable 
excitation wavelengths (^gy.) for each of the six PAH 
metabolites. Earlier work (66) emphasized the importance 
for analyses of generating standard FLN spectra for at least 
two excitation wavelengths, and this will be underscored 
again in what follows. The fluorescent parent chromophores 
associated with the metabolites are either anthracene, 
chrysene, pyrene, or phenanthrene. It was important for 
assessing sample purity to first obtain FLN spectra with 
(0,0) excitation so that the vibrational frequencies and 
relative intensities could be compared with those of the 
parent chromophores. Fluorescence line narrowing was 
exhibited by all metabolites studied. Typical of the 
spectra obtained are those shown in Figure 11 for B[a]AT-l 
and CT, while a partial vibrational analysis for each of the 
metabolites is given in Table 2. On the basis of the close 
agreement between the metabolite FLN spectra and those of 
their respective parent chromophores, the sample purities 
are judged to be high. We note that B[a]AT-8, CT, and 
5-MeCT possess the phenanthrene chromophore and, therefore, 
that their spectra are quite similar. However, these three 
Figure 11. Standard FLN spectra of B[a]AT-l (top) and CT 
(bottom) following (0,0) excitation at 4.2 K. 
L labels laser peak. Vibrational lines are 
labeled in energy units of inverse centimeters 
relative to the excitation energy. See Table 
2 for partial vibrational analysis of all six 
metabolites 
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Table 2. Partial vibronic analysis of components following 
(0,0) excitation 
concentration 
(_wm) 
pure mixture vibration frequencies, cm 
compound 
^ex(O'O)' nm - 1  
B[a]AT-l, 386.1 103 9 
B[a]AT-8, 351.7 109 41 
5-MeCT, 356.9 170 26 
1187 (w), 1265 (m), 1411 
(s), 1558 (m) 
1358 (s), 1441 (m), 1607 (m) 
648 (w), 887 (w), 1364 (s), 
1440 (m), 1594 (m) 
CT, 348.7 
B[a]P-diol, 
373.5 
B[a]PT, 377.1 
104 16 872 (w), 1366 (s), 1443 (m) , 
1601 (m) 
308 4 329 (m), 492 (w), 536 (w), 
878 (w), 1391 (s) 
220 46 597 (w), 792 (m), 856 (m), 
1116 (m), 1249 (s), 1291 
(m), 1414 (s), 1563 (m) 
Assignments are ± 10 cm . Intensities are designated 
(w), < 0.2 of major peak; (m), 0.2-0.5; (s), > 0.5 of major 
peak. 
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metabolites can be distinguished on the basis of selective 
excitation of their (0,0) absorption bands. 
In all tables and figures, and throughout the text laser 
excitation wavelengths will be given in nanometers. 
However, the lines in the FLN spectra are due to vibrations 
of the molecule and are thus labeled in units of vibrational 
energy, wavenumbers (cm"^). This vibrational energy is the 
difference in energy between the excitation and emission 
wavelengths. For (0,0) excitation, as in Table 2 and Figure 
11, the energies, therefore, may be directly interpreted as 
ground-state vibrational frequencies. 
For any low-temperature high-selectivity fluorescence 
technique, the electron-phonon interaction is a potential 
problem for selectivity (76,77). If sufficiently strong, it 
produces broad low-frequency phonon sidebands (PSBs) which 
build on the sharp zero-phonon vibronic features of the 
fluorescence spectrum. For very strong coupling, the zero-
phonon lines (ZPLs) are lost, as is the high selectivity of 
FLN. The metabolite which exhibits the strongest coupling, 
moderately strong, is B[a]AT-l, which possesses the 
anthracene chromophore. This observation is consistent with 
earlier results on anthracene and substituted anthracenes 
(73). The moderate electron-phonon coupling for B[a]AT-l, 
Figure 11, posed no problem for the analysis of the six-
component metabolite mixture. The benzo[a]pyrene 
66 
metabolites were previously shown to exhibit weak coupling 
(61). 
For a fluorescence-based technique, the distinction 
between the unsubstituted chrysene metabolite, CT, and its 
analogue, 5-MeCT, is a formidable challenge and important 
since 5-methylchrysene is a potent carcinogen while chrysene 
is not (78,79). However, the (0,0) absorption band of 
5-MeCT is significantly red-shifted (~ 600 cm~^) relative to 
CT so that in a binary mixture of the two metabolites, 
5-MeCT can be determined without any interference from CT 
when origin excitation for 5-MeCT is used. The key question • 
is whether a suitable for FLN from CT will allow for its 
characterization since this excitation will excite 5-MeCT 
with considerable excess vibrational energy. The 
concentrations of the two components are low enough to 
preclude any effects of interaction on the spectra. But 
because 5-MeCT is excited with excess vibrational energy, 
the utility of FLN for analysis may be negated if the 
fluorescence of 5-MeCT is broad enough to obscure narrow 
lines arising from CT. This will be an ever-present problem 
in doing direct mixture analysis, and different mixtures may 
have to be characterized at different excitation 
wavelengths. 
Figure 12 shows the FLN spectrum of the binary mixture 
for a XQ J J  coincident with the (0,0) absorption band of CT. 
Figure 12. FLN spectrum of mixture of CT (60 ym) and 
5-MeCT (73 ym), following excitation of the 
(0,0) transition of CT 
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All four main peaks for the CT spectrum are evident, as 
shown in Table 2. Interestingly, the set of four 
line-narrowed bands near 355.5 nm comprises the (0,0) 
fluorescence multiplet structure for 5-MeCT arising from the 
excitation of a vibrationally congested vibronic absorption 
band, as described previously. The energy differences 
between these bands and the laser excitation frequency 
provide the frequencies of the overlapped excited state 
vibrations which are 426, 495, 546, and 632 cm ^. The 
multiplet structure provides a fingerprint for 
identification which may be more useful than the pattern 
arising from (0,0) excitation. The broad fluorescence at ~ 
373.5 nm in Figure 12 results from the overlap of 
fluorescence lines from each of the four excited-state 
vibrational isochromats excited by the laser. Note that the 
peak at 1901 cm ^ in the spectrum of Figure 12 is separated 
from the highest intensity 5-MeCT (0,0) fluorescence 
multiplet component at 546 cm ^ by ~ 1356 cm ^, which is the 
major ground-state fluorescence line, shown in Table 2. 
We turn now to the analysis of a six-component PAH 
metabolite mixture, as given in Table 2. In view of earlier 
work on FLN of DNA-PAH metabolite adducts (61), resolution 
of the six metabolites would augur well for the resolution 
of a comparable mixture of adducts. Previous applications 
of FLN have emphasized the use of a which excites a 
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single isochromat (66,73). Indeed, for a binary mixture of 
B[a]PT and B[a]P-diol, excitation of the two (0,0) 
absorption bands resulted in each case in a single-component 
FLN spectrum, with no interference from the second component 
(61). However, mixtures generally do not lend themselves to 
such convenient analysis. Interference from broad 
fluorescence from other components can obscure the FLN 
spectrum of the component of interest. For example, if in 
the analysis of 5-MeCT, = 356.9 nm is used, providing 
(0,0) excitation for 5-MeCT, then serious interference from 
the fluorescence of B[a]P-diol occurs. This X excites 
B[a]P-diol in a vibrationally congested region with ~ 1300 
cm of excess vibrational energy, cf. Table 2. Because of 
interferences of this nature, (1,0) excitation for the 
components of interest proved to be the key to resolving the 
mixture. In this regard, the multiplet origin structure 
afforded by (1,0) excitation was particularly helpful. 
In the process of analysis of the mixture, about.30 
fluorescence spectra were obtained, and, except for 
B[a]AT-8, every component was identified by its FLN spectra 
at two or more excitation wavelengths. As examples. Figures 
13 and 14 are presented in order to discuss the analysis 
procedure. The FLN spectrum in Figure 13 for the mixture 
was obtained with = 342.2 nm which provides (1,0) 
excitation for CT with ~ 550 cm ^ of excess vibrational 
Figure 13. FLN spectrum of mixture of six PAH 
metabolites. Peaks are labeled as being due 
to B[a]AT-8, 5-MeCT, or CT. Inset: partial 
spectrum of pure CT, showing lines used for 
identification 
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Figure 14. FLN spectrum of six-component mixture. Peaks 
are labeled as B[a]AT-l, B[a]P-diol, and 
B[a]PT. Inset; partial spectrum of 
B[a]P-diol, showing lines used for 
identification 
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energy. The inset spectrum was obtained for CT by itself 
and with the same excitation wavelength. Thus, the 517-, 
547-, and 635-cm~^ bands represent the origin multiplet 
structure for CT, and these frequencies correspond to the 
excited-state vibrations being pumped. For completeness, 
the FLN spectra for = 342.2 nm were obtained for pure 
B[a]AT-8 and 5-MeCT and were used to assign the remaining 
bands in Figure 13. This would not be necessary if one is 
interested in analyzing only for CT. In Figure 14, the 
= 366.1 nm was chosen to provide (1,0) excitation for 
B[a]P-diol, and the inset spectrum obtained for the pure 
diol establishes its assignments in the mixture spectrum. 
The multiplet origin structure for B[a]P-diol is 
particularly rich. The assignments in the mixture spectrum 
for B[a]PT and B[a]AT-l were made on the basis of the A = 
ex 
366.1 nm FLN spectra of the pure compounds. The procedure 
just described was followed for the analysis of the mixture 
for each of the metabolites. 
Following the successful resolution of six metabolites, 
a five component mixture of DNA adducts was attempted (74). 
The five DNA adducts used in this study are shown in Figure 
7. The parent chromophores are phenanthrene, anthracene, 
and pyrene. As in the study of mixtures of PAH metabolites, 
the DNA adducts were individually characterized, and several 
excitation wavelengths were selected for each.. As expected. 
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fluorescence line narrowing was exhibited by each of the 
adducts. However, for adduct V, there is a significant 
intensity in the PSBs, and the ZPLs, although sharp, are 
weak. As discussed earlier the ratio of ZPL intensity to 
that of FSB of the corresponding metabolite was also fairly 
low, and therefore the intense PSBs were not unexpected. 
Although this did not prove to be an obstacle in analyzing 
mixtures of DNA adducts, it did make identification of the 
adduct in the presence of the tetrol more difficult. None 
of the other adducts or tetrols studied exhibited 
significant PSB intensity. 
It is interesting to note that although there is good 
correlation between the vibrational frequency spacings for 
the DNA adducts and those of the unbound tetrol, there is 
also a small but consistent red shift (about 100-300 cm~^ 
depending on the adduct) in the + Sq absorption spectrum 
of the adduct. The red shifts observed for all the DNA 
adducts were important in allowing adducts to be 
spectroscopically distinguished from their corresponding 
tetrols. 
Standard FLN spectra have been generated for the DNA 
adducts shown in Figure 7. For each adduct spectra were 
obtained for at least two excitation wavelengths and a 
partial vibrational analyses completed as shown in Table 3. 
The resolution of a mixture of these five adducts is not a 
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Table 3. Partial vibronic analysis of components 
DNA adduct Concentration Vibration frequencies, 
(0,0), nm in mixture (uM) cm ^ 
B[a]ADE-l-DNA, 391 17 ES; 1390, 1180, 596, 
485, 439 
GS; 1558, 1420, 1270 
B [a]ADE-8-DNA, 352 34 ES; 1600, 1520, 1438, 
1386, 1281, 1160, 
1022, 866, 694, 618 
GS; 1603, 1444, 1359, 
1248, 1044, 880, 
729, 638 
CDE-DNA, 350 7 ES; 1384, 943, 846, 
703, 633, 546, 519 
GS; 1605, 1442, 1365, 
1044, 873, 582, 233 
5-MeCDE-DNA, 356 16 ES; 1392, 1354, 1043, 
922, 871, 800, 631, 
562, 490, 447 
GS; 1604, 1448, 1372, 
1364, 1069, 889, 
655 
B(a]PDE-DNA, 378.5 3 ES; 1109, 1045, 957, 
830, 761, 579, 465 
• GS; 1637, 1560, 1413, 
1249, 1120, 855, 
787, 596 
ES and GS represent excited state and ground state 
vibrations, respectively. 
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trivial problem since the B[a]ADE-DNA (I), CDE-DNA (II), and 
B[a]ADE-8-DNA (IV) adducts each possess phenanthrene as the 
parent fluorescent chromophore. Nevertheless, Figure 15 
demonstrates that with an excitation wavelength of 343.1 nm 
these three adducts are readily distinguished. This figure 
contains portions of the standard FLN spectra for each of 
the adducts that are readily correlated with the peaks which 
appear in the mixture spectrum. The above excitation 
wavelength provides (1,0) type excitation for each adduct, 
and the FLN structure (peaks labeled with excited-state 
vibrational frequencies in cm~^) corresponds to multiplet 
origin structure. In part the resolution of adducts I, II, 
and IV depends on their + Sg absorption spectra being 
shifted relative to each other. It is adduct I whose 
absorption lies furthest to the red, consistent with its 
labeled vibrational frequencies being the highest (1040 and 
1348 cm ^). Figure 16 shows a portion of the FLN mixture 
spectrum obtained for an excitation wavelength of 369.5 nm. 
With this spectrum B[a]PDE-DNA (III) and B[a]ADE-l-DNA (V) 
are readily distinguished. Again (1,0) type excitation for 
both adducts is provided by = 369.5 nm. Sharp zero-
phonon lines for B[a]ADE-l-DNA at 1181 and 1391 cm ^ are 
apparent, superimposed on the broad phonon side profile, 
centered near 395 nm. It is possible that different host 
glasses may lead to a diminution of phonon sideband activity 
Figure 15. FLN spectrum from a mixture of the five DNA 
adducts obtained with (1,0) type excitation 
at 343.1 nm, T = 4.2 K. Peaks labeled A, B, 
and C are due to the three individual adducts 
pictured. See text and Table 3 for further 
details 
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Figure 16. FLN spectrum from a mixture of the five DNA 
adducts obtained with (1,0) type excitation, 
T = 4.2 K. Peaks are labeled as being due to 
either B[a]PDE-DNA (III) or B[a]DE-l-DNA (V) 
as indicated by the inset spectra for pure 
adducts III and V 
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for adduct V. Note that this activity for B[a]PDE-DNA is 
weak with the FLN spectrum dominated by zero-phonon lines 
(e.g., at 581 cm"^, which is an excited-state vibration). 
Thus, as was the case for the mixture of the tetrols 
associated with the adducts of Figure 15, it shown that 
(1,0) type vibronic excitation affords facile resolution for 
a comparably complex adduct mixture. 
A further test of the selectivity of FLN spectrometry 
was the identification of DNA adducts in the presence of the 
corresponding tetrols. For each of the five pairs of 
compounds tested, the DNA adduct could be identified in 
mixtures containing approximately equal amounts of each. 
The basis for this identification is the small red shift in 
the absorption spectra and differences in the excited state 
vibrations of the DNA adducts as compared with the tetrols, 
as demonstrated in Table 4 for BPDE-DNA and B[a]PT. 
Excitation into a region of origin or (0,0) absorption for 
both the bound and unbound metabolites yields a fluorescence 
spectrum with lines from both generally overlapped. The 
ground-state vibrational energy differences between the 
bound and unbound metabolite determine the displacements 
between overlapped lines. Typical displacements are 
11 ^ — 1 
small, ^ cm 
The reason is that (0,0) or origin excited fluorescence 
spectra from a given parent PAH are not significantly 
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Table 4. Ground and excited state vibrational frequencies 
(cm ) of B[a]P tetrol and BPDE-DNA in glass at T 
= 4.2 K 
B[a]P Tetrol BPDE-DNA 
Ground State Ground State 
Vibrations Excited State Vibrations Excited State 
( c m  ^ =  V i b r a t i o n s  ( c m  ^ =  V i b r a t i o n s  
377.1 nm (cm 377.1 nm (cm 
464 s 454 m (1) 468 w 452 m (7) 
477 s 471 m (1) 478 w 465 s (7) 
510 m (1) 512 w 476 m (7) 
559 s (1) 562 s 504 m (7) 
594 s 532 m (1) 596 s —  —  —  (7) 
745 m 546 m (1) 751 m 541 m (7) 
786 s 578 s (1) 787 m 579 s (7) 
848 s 757 s (2) 855 s 761 s (8) 
1118 s 827 m (2) 1118 s 830 s (8) 
1179 m 956 s (3) 1179 m 957 s (8) 
1249 s 1049 m (3) 1249 s 1045 s (8) 
1290 m 1111 s (3), (4) 1289 m 1109 s (8) 
1414 s 1158 s (4) 1413 s —  — —  (9) 
1556 s 1179 m (4) 1560 s — — — (9) 
1592 m 1330 m (5) 1592 m (9) 
1631 m 1379 m (5) 1637 m 1379 s (9) 
1441 m (5), (6) 1435 s (9) 
1517 m (6) —  —  —  (10) 
1562 s (6) (10) 
1615 s (6) 1617 m (10) 
Excited state vibrational intensities are dependent on 
s = strong (1): 
Jex 
368.3 nm (6) ; 
X- : 
355.4 nm 
m = medium (2) ; 365.6 nm (7) : 371.5 nm 
w = weak (3): J®" 362.5 nm (8) ; = 365.5 nm 
(4): , ex 
Ijex 
ex 
360 nm (9) : 
ex 
359.5 nm 
(5): = 358 nm (10) ; 353.5 nm 
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perturbed by substituent groups. That is, the ground state 
vibrational frequencies and (0,1) vibronic intensities are 
not very sensitive to ring substitutions. On the other 
hand, the vibrational structure and dynamics in the state 
are often sensitive to ring substitution. The reason 
appears to be connected with Herzberg-Teller vibronic 
coupling, vibronically induced anharmonicity and the 
symmetry reduction resulting from substitution (80). Thus 
the states of PAH such as naphthalene, phenanthrene, 
pyrene and benzo,[a]pyrene, whose - Sg energy gaps are 
only a few thousand cm are expected to exhibit the above 
sensitivity. Vibronic coupling effects become more 
pronounced as the energy gap between the two coupled 
electronic states decreases. For the DNA-PAH adducts and 
unbound metabolites, vibronic excitation at ~ 500 cm ^ above 
the (0,0) transition revealed a rich and very diagnostic 
multiplet origin structure in fluorescence consisting of 
several bands (analogous to the doublet shown in Fig. 2B). 
With these facts in mind it becomes apparent that by 
using (1,0) excitation the excited-state vibrations that are 
pumped, by a specific in a DNA adduct will be different 
from those in the corresponding tetrol. Therefore, the 
distinction between the two is trivial based on origin 
multiplet structure. An example of this is shown in Figure 
17 for 5-MeCDE-DNA and 5-MeCT using = 342.2 nm. The 
Figure 17. FLN spectra of a mixture of a DNA adduct and 
corresponding tetrol. Top spectrum (pure 
5-MeCT) and bottom spectrum (pure ^ 
5-MeCDE-DNA) shows lines labeled in cm" used 
for identification. See text for further 
discussion. Results, not given, have been 
obtained which establish that each and every 
adduct of Figure 7 can be distinguished from 
its corresponding tetrol 
1040 . I  
1 3 4 8 ,  I  
1 3 8 0 ,  I  
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zero-phonon features are labeled with excited-state 
vibrational frequencies. Both the 5-MeCT and the 
5-MeCDE-DNA exhibit weak electron-phonon coupling. 
Finally, a complex mixture of all six metabolites and 
the adducts 5-MeCDE-DNA (I) and B[a]PDE-DNA (III) was 
analyzed. Resolution by FLN was straightforward when 
wavelengths were used that provided the best 
separation of the two adducts from their corresponding 
tetrols. Some of the results are shown in Figures 18 and 
19. For = 342.2 nm, peaks from three tetrols and 
5-MeCDE-DNA are observed. Figure 18. The most important 
features are labeled with the name of the compound and 
excited-state vibrational frequencies. When = 366.1 nm 
is used, zero-phonon features from the remaining three 
metabolites are observed, as shown in the lower spectrum of 
Figure 19. This spectrum was obtained with a PMT detector 
and without gating. The feature at 1110 cm~^, which is a 
shoulder riding on the much'more intense emission from the 
B[a]AT-l tetrol is due to the B[a]PDE-DNA adduct. The 
parent chromophore of the interfering tetrol is anthracene. 
The upper spectrum of Figure 19 was obtained with the 
gateable diode,array-OMA system. The fluorescent parent 
chromophore of the B[a]PDE-DNA adduct is pyrene. Figure 7. 
Since the lifetime of pyrene is ~ 400 ns (81) and that of 
anthracene is ~ 5 ns, delay of the gate pulse will lead to a 
Figure 18. FLN spectrum of an eight-component mixture 
including six metabolites and the 5-MeCDE-DNA 
and B[a]PDE-DNA adducts. L labels the laser 
peak = 342.2 nm), T = 4.2 K. Bands are 
labeled as 5-MeCDE-DNA, CT, 5-MeCT, and 
B[a]AT-8 and assigned on the basis of 
standard spectra for the pure individual 
compounds 
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Figure 19. FLN spectra of an eight-component mixture 
(see Figure 18 caption) obtained for 
excitation wavelength of 366.1 nm. The lower 
spectrum was obtained ungated with a PMT, and 
only bands due to three metabolites 
(B [a]J>-diol, B[a]PT, B[a]AT-l) are readily 
apparent based on standard spectra. The 
upper spectrum (insert) was obtained with a 
gateable intensified diode array-OMA (80-ns 
gate delay) and proves that the weak feature 
at 1110 cm~^ in the lower spectrum is due to 
the B[a]PDE-DNA (see text) 
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marked reduction of the B[a]AT-l emission intensity. The 
upper (inset) spectrum of Figure 19 was obtained with a gate 
delay of 80 ns, and all features can be assigned to 
B[a]PDE-DNA. Thus, temporal discrimination greatly enhances 
the versatility of FLN for analysis of complex DNA-PAH 
adduct mixtures. 
C. Hole Burning Considerations 
Turning to the question of detection limits we note that 
with a conventional prototype FLN system, which employed a 
low power (~ 2 mW average power) N^^pu^ped dye laser, a 
detection limit for damage of ~ 5:10^ base pairs for ~ 30 Ug 
of DNA has been reported for the BPDE-DNA adduct at an FLN 
resolution of ~ 10 cm ^ (74). This corresponds to the 
detection of ~ 1 pmol of the bound metabolite, which is 
roughly three orders of magnitude too high for practical 
biological applications. Calculations indicated that the 
FLN system described in Section II should provide a 
detection limit of ~ 1 fmol. It should be noted that the 
+ Sq absorption transition of pyrene is weak (e^^^ ~ 25- at 
room T in ethanol solution) and that its fluorescence 
quantum yield is ~ 0.65 (81). For more strongly absorbing 
and fluorescent chromophores such as the aflatoxins one 
would anticipate lower detection limits. 
Prior to the studies on BPDE-DNA and B[a]P tetrol, the 
FLN system of Figure 9 was used to determine the detection 
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limits for the moderately strong fluorescers 1-methylpyrene 
and anthracene. For both compounds a FLNS detection limit 
of 1 fmol or ~ 0.2 pg can be achieved at a spectral 
resolution of ~ 10 cm This value would correspond to the 
detection and characterization of an equivalent 30 ug DNA 
p 
sample having a damage level of 1:10 bases. Thus, the FLN 
system appeared to have the capability to detect and 
characterize the low DNA damage levels of iji vivo biological 
samples. 
As model compounds, B[a]P tetrol and BPDE-DNA were 
analyzed. Using nondegassed samples, excitation of the 
pyrene chromophore with sufficiently high laser intensity 
led to photodegradation and, as a consequence, spectral 
degradation. Figure 20 shows the effect of photodegradation 
on the FLN spectrum of a nondegassed B[a]P tetrol sample; 
the upper curve in Figure 20 is taken with low laser power 
density (5 mW/cm )r and the lower curve after scanning the 
laser through the very broad absorption region ((0-0) band) 
at high laser power density (~ 600 mW/cm ). One can clearly 
see that significant changes have taken place — the ZPLs 
have disappeared, leaving only a broad fluorescence 
background. Warming the sample to room temperature and then 
cooling to low temperature (4.2 K) did not restore the ZPLs 
— the photodegradation was not thermally reversible. 
Figure 20. FLN spectrum of B[a]P-tetrol at T = 4.2 K, 
^ex ~ 355.4 nm. Upper curve is taken with 
low average laser excitation power density, I 
= 5 mW/cm . Lower curve is taken after 
scanning the laser through the very broad 
absorption region (0,0) band at high laser 
power (I = 600 mW/cm ) 
FLUORESCENCE INTENSITY 
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Similar results have been obtained for nondegassed BPDE-DNA 
samples. 
A brief discussion of spectral hole burning is 
appropriate at this point to better understand the observed 
photodegradation of the fluorescence signal. There are two 
types of spectral hole burning: photochemical hole burning 
(PHB) and non-photochemical hole burning (NPHB). With an 
understanding of FLN, as presented in section I, PHB follows 
in a natural way. It is apparent that if the species giving 
rise to the absorption is photoreactive, isochromat 
selective photobleachifig can occur. Hole burning is based 
on the ability of matrix-isolated optical absorber to 
undergo a reaction while in an excited state (82-84). This 
reaction can be a chemical modification, e.g., irreversible 
molecular fragmentation, reversible tautomerization or 
photoionization (in the case of trapped electrons in organic 
glasses) (82,83). In the case of NPHB the mechanism 
involves a structural relaxation that changes the physical 
state of the system (triggered by host two level system 
(TLS) transitions and/or rearrangement of local host 
structure) (83). Since these processes lead to a change of 
the optical transition energy a spectral hole is produced 
whose width is determined by dephasing processes acting on 
the molecule under consideration and, at least partly, by 
time dependent spectral diffusion (85-87). Zero-phonon 
Figure 21. Inhomogeneous line broadening and hole 
burning. (a) Inhomogeneous line broadening 
and (b) photochemical and nonphotochemical 
hole burning, ~ few hundred cm ^ for 
glasses; (homogeneous linewidth) j< 0.1 
cm ^ at T ~ 1.5 K for organic molecules in 
glasses. In (b) (the bottom schematic) the 
"product" corresponds to new impurity-glass 
site configurations produced by light induced 
TLSejjt relaxation 
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Figure 22. The two-level system (TLS) model for 
nonphotochemical hole burning. The 
subscripts a and 6 label the TLS that 
interact with the impurity in its ground and 
excited electronic states. The tunnel 
frequency, W, depends on the tunnel parameter 
X which is defined as d(2mV)^/^/h, where m is 
the tunneling mass. The frequency Wg is that 
of the burn laser 
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holewidths are usually very narrow 0.2 cm~^)/ and widths 
as narrow as ~ 100 MHz have been observed at T = 1.5 K 
(83,84,88). 
Photoreactivity is not required in NPHB (82-84); what is 
required is a host with a "faulty memory" for its 
pre-excitation configuration near the absorber. That is, 
upon completion of the cycle from ground state to excited 
state and back to the ground state, the host configuration 
must have changed more or less permanently if persistent 
holes are to be produced (bottom schematic of Fig. 21). 
With perhaps one or two exceptions, NPHB has only been 
observed in glasses and polymers. Given the immense 
disorder which exists in such hosts (89), this restriction 
is perhaps now not so surprising. 
In Figure 22 the simple TLS model for the NPHB mechanism 
(90) is shown. It approximates the glass bistable 
configurations with a distribution of asymmetric 
intermolecular double well potentials (TLS). There is a 
distribution of barrier heights (V), asymmetries (A) and 
displacements (d), and, of course, there may also be 
distinctly different intermolecular coordinates, q. From 
Figure 22, a mechanism for persistent NPHB at T = Tg (burn 
temperature) becomes apparent if it is postulated that a 
subset of the distribution of TLS interacting with the 
impurity has the following properties at Tg; relaxation 
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between the two minima for the ground state is slow on the 
time scale of the experiment, while for the excited impurity 
the relaxation is competitive with the excited state decay. 
For example, with the frequency tuned to the "left" 
optical transition, barrier hopping or tunneling in TLSg 
leads to population of the right-well configuration in the 
ground state. The degree of competitiveness determines the 
hole burning quantum efficiency (83,84). 
Summarizing, the general definition of NPHB is 
isochromat selective photobleaching due to the production of 
a glass state which, at Tg, is thermally inaccessible to the 
original state. For low temperatures NPHB is the result of 
phonon assisted tunneling of TLS and provides a tangible 
illustration of TLS relaxation (83,84). 
As a first measure to reduce or eliminate spectral hole 
burning the samples were degassed, as described in the 
experimental section, to remove oxygen. For degassed 
samples the spectral degradation is less significant. The 
results indicate that a significant photodegradation route 
in nondegassed samples is due to photooxidation. Figure 23 
shows the FLN spectrum of a degassed BPDE-DNA sample having 
a damage level of 8:10^ bases (curve 1) and a higher 
modification BPDE-DNA sample (curve 2). The signal/noise 
ratio of the strongest peak in curve 1 is greater than 20:1, 
7 
resulting in a detection limit of ~ 1:10 bases for 
Figure 23. FLN spectra of BPDE-DNA (degassed) with a 
modification level of 8 adducts in 10^ bases 
(curve 1) and a modification level of 1 
adduct in 183 DNA bases (curve 2), = 
369.6 nm 
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BPDE-DNA. For a DNA sample of 30 yg, this corresponds to ~ 
10 fmol of adduct detected. This is still an order of 
magnitude greater than the 1 fmol detection limit mentioned 
earlier, and, indeed, while the photodegradation due to 
photooxidation has been eliminated in the degassed samples, 
an efficient NPHB process is still present, which is 
responsible for the higher than expected limit of detection. 
Figure 24 illustrates the effect of NPHB on the FLN 
spectrum of degassed BPDE-DNA sample. Figure 24a shows the 
FLN spectrum at short irradiation time and low laser power 
2 density (85 mW/cm ). Spectral hole burning was then carried 
2 
out with high laser power density (400 mW/cm ), and Figure 
24b shows the decrease of the intensity of the strongest ZPL 
((0-0) site at (0 = 579 cm ^ ) as a function of irradiation 
time. The fluorescence spectrum after hole burning is shown 
in Figure 24c, where one can readily observe that the ZPLs 
have been eliminated. 
Non-photochemical hole burning a thermally reversible 
process, that is, by simply warming the sample to room 
temperature the holes in the absorption profile are 
"refilled" and the absorption spectrum returns to its 
original form. However, during the actual experiment, NPHB 
reduces both the selectivity and sensitivity of the FLNS 
method. The sharpness of the ZPLs disappears due to the 
photobleaching of the sites which have their zero-phonon 
Figure 24. Effect of NPHB as a function of laser power 
density and time, a) FLN spectrum of 
BPDE-DNA (degassed). Excitation laser power 
density I = 85 mW/cm^, X = 369.6 nm. The 
numbers correspond to excited state 
vibrations (in cm ^) 
b) Decay of the integrated fluorescence 
intensity of the 579 cm~^ peak (Fig. 24a) for 
a laser excitation power density of 400 
2 
mW/cm 
c) Resulting FLN spectrum after burning (at 
2 400 mW/cm ) for 30 min. The experimental 
conditions are as in Fig. 24a 
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transition at the laser frequency, so the characteristic FLN 
fingerprint of the molecule under study is eventually 
destroyed. Also, since the NPHB process removes some of the 
absorbers from their initial position within the absorption 
profile (at the laser frequency), the fluorescence intensity 
necessarily decreases. This is particularly troublesome 
when one wants to measure very small fluorescence signals 
from low concentration (~ 1 fmol) samples, since in those 
cases it is necessary to use high laser excitation power 
densities to detect any fluorescence, but the high power 
densities also accelerate the NPHB process. Thus, in order 
to improve the limits of detection for BPDE-DNA (and other 
samples in which NPHB occurs), methods of reducing NPHB were 
necessary. 
As discussed earlier, line-narrowed spectra can be 
obtained by exciting either the origin or vibronic 
transitions of a given molecule. In the presence of NPHB, 
vibronic excitation is preferable for T ^  4 K. This is true 
because the homogeneous vibronic linewidths, , are much 
broader than the origin linewidth (mainly due to rapid 
vibrational relaxation of the vibronic levels). Therefore, 
vibronic excitation allows one to use excitation power 
densities of roughly an order of magnitude higher (compared 
to those used for origin excitation) before optical 
saturation of the transition occurs. 
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As Figure 24 clearly demonstrates, though, excitation 
into the vibronic region of the absorption profile does not 
sufficiently reduce NPHB in BPDE-DNA samples, so other 
methods of decreasing the photobleaching were sought. 
Simultaneously scanning and the observation wavelength 
(Xobs^ at a constant energy separation reduces the NPHB 
process by limiting the time that each isochromat is exposed 
to the laser. The spectra obtained indicate that this 
procedure does not distort the shape of the FLN spectra (at 
least for scans of ~ 50 cm~^ or less) and that the 
fluorescence intensity is increased. The depletion of the 
ground state population can be decreased by subjecting the 
sample to high intensity white light pulses. This procedure 
decreases the NPHB effects and thus increases fluorescence 
(91). In addition, the theory of dispersive kinetics and 
experimental results indicate that the quantum efficiency 
for hole burning decreases at higher temperature (84), so 
another way to decrease the NPHB process is to perform the 
FLNS experiments at temperatures of ~ 10-30 K. 
The preceding discussion indicates that combining 
vibronic (1,0) excitation, simultaneous scanning, white 
light restoration pulses, and using a temperature slightly 
higher than 4.2 K should enable a lower FLNS limit of 
detection for BPDE-DNA to be realized. Indeed, this is the 
case, as is shown in Figure 25. .Vibronic excitation is 
Figure 25. FLN spectrum of BPDE-DNA (degassed) with'a 
modification level of 8:10^ synchronously 
scanning and X^^^ over 40 cm~^ and using 
white light restoration pulses (see text) at 
T = 20 K, (I = 450 mW/cm^). Signal/noise 
ratio of the most intense peak is greater 
than 80. Note that the bottom axis is in 
cm which represents the frequency 
separation between the laser and the observed 
fluorescence 
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employed, and the laser and monochromator have been 
synchronously scanned over ~ 4p.cm~^. one msec white light 
restoration pulses, delayed 1 msec after the laser 
excitation pulse have also been used, and. the spectrum 
obtained at T = 20 K. The signal/noise ratio of the 
strongest peak in Figure 25 is greater than 80, so a limit 
of detection of ~ 3 adductsxlO^ bases, for a 20 Pg DNA 
sample, is obtained. This corresponds to ~ 2 fmol of adduct 
detected and illustrates that FLNS does have the requisite 
sensitivity to analyze and characterize the typically low 
DNA damage levels of biological samples. 
In the presence of the NPHB process, the selectivity of 
the FLN spectra depends on the exposure time. Therefore, to 
increase the selectivity, a new analytical approach which 
combines FLNS with the NPHB process was developed. It is an 
extension of the procedure used by Bogner and Schwarz (92) 
and Funfschilling et al. (93) to describe the correct shape 
of phonon wings and the electron-phonon coupling. In 
contrast to ref. 92 and 93, for the reasons discussed above 
is used. 
In the standard FLNS method the zero-phonon site 
selection is not perfect, i.e., a significant fraction of 
the fluorescing molecules are excited through phonon wing 
absorption. The resulting fluorescence spectrum consists of 
narrow ZPL and broad-band fluorescence arising from various 
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phonon contributions, depending on the electron-phonon 
coupling strength (62). Ideally one would like to observe 
only the spectrum of the molecules which have their 
zero-phonon transition at the laser frequency and avoid the 
broad-band phonon fluorescence. To get better selection, 
therefore, one has to measure an FLN spectrum "A" and then 
after a given irradiation time (after hole-burning), measure 
the next spectrum "B". Then the "difference" fluorescence 
spectrum "A" - "B", representing the FLN spectrum shows very 
sharp ZPL with their real phonon wings (at least for short 
burning times to avoid saturation effects), thus increasing 
the selectivity of the standard FLNS method. These results 
are presented in Figure 26a, b and c for BPDE-DNA. The most 
important feature of the above procedure is the fact that 
one can use much higher laser intensities (to increase 
fluorescence intensity) and, although the spectra "A" and 
"B" are broader with less pronounced ZPL, the difference 
spectrum will always show a sharp fingerprint of the 
molecules under study, provided that all molecules excited 
at through their ZPL have not been totally burned out. 
This selective difference spectra technique can also be 
applied to short-lived fluorescing species, where gated 
fluorescence detection is not available and/or scattered 
laser light contributes to the signal. The FLN and 
difference spectra for 6-MeB[a]P are presented in Figure 27. 
Figure 26. FLN spectra of BPDE-DNA, - 369.6 nm 
a) Spectrum obtained with a laser excitation 
2 power density, I = 85 mA/cm and an exposure 
time of ~ 100 sec 
b) Spectrum obtained under experimental 
conditions as in (a), following a 100 sec 
2 
exposure to 400 mW/cm excitation power 
density 
c) The "difference" spectrum ((a) - (b)) 
obtained, as discussed in detail in the text. 
The numbers correspond to excited state 
vibrations in cm~^ (see Table 4) 
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Figure 27. FLN spectra of 6-MeB[a]P, ~ 388 nm 
a) Laser excitation power density, I = 80 
2 
mW/cm 
b) Identical conditions to (a) after several 
minutes of continuous irradiation with the 
2 
same laser power density, I = 80 mW/cm 
c) The "difference" spectrum showing the 
useful analytical peaks labeled in cm ^ 
FLUORESCENCE INTENSITY 
119 
The spectra were recorded in the continuous mode (not gated) 
of the OMA system, and the high scattered laser background 
is virtually eliminated in the difference spectrum. 
The spectral subtraction method takes advantage of the 
fact that the broad-band fluorescence arising from the 
various phonon contributions is difficult to bleach (for 
those cases in which the electron-phonon coupling is weak) 
and is, therefore, fairly consistent. By taking consecutive 
spectra and subtracting the second from the first, the 
relatively constant phonon contribution to the fluorescence 
spectrum is eliminated, leaving sharp ZPLs in the difference 
spectrum. Thus the constructive use of NPHB in FLNS 
experiments significantly increases the FLNS selectivity, 
and is therefore a potentially powerful technique. 
Detectability is also improved since higher laser power 
densities can be used, increasing the fluorescence 
intensity. 
D. Applications 
1. BPDE-globin adducts 
In addition to the detection of DNA-adducts, the high 
selectivity and detectability of FLNS is applicable for the 
analysis of globin-carcinogenic metabolite adducts. One 
example is BPDE-globin, in which BPDE is covalently bound to 
globin. Figure 28 presents spectra of BPDE-globin excited 
Figure 28. FLN spectra of BPDE-globin excited in the (1-0) 
band: A) = 369.6 nm and B) = 368.6 nm. 
The numbers correspond to the excited state 
vibrations, in cm~^ (see Table 5) 
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Table 5. The ground and excited state vibrational 
frequencies (cm~^) of BPDE-globin in polar glass 
at T = 4.2 K 
BPDE-Globin 
Ground State Vibrations Excited State Vibrations 
(cm (cm 
(Xg^ = 377 nm) 
341 m 347 (1) 
360 w 381 (1) 
425 w 409 (1) 
464 m 457 (1) 
688 w 473 (1,2,3) 
760 w 485 (2,3) 
786 s 502 (2) 
821 w 542 (3) 
845 s 552 (3) 
909 m 583 (2,3,4) 
968 w 622 (3,4) 
977 w 653 (4) 
1047 w 675 (4) 
1113 m 720 (5) 
1176 w 745 (4,5) 
1246 m 764 (4,5,6) 
1411 s 833 (5,6,7) 
1558 m 894 (6,7) 
1593 w 960 (6,7) 
1633 w 1021 (7) 
1028 (7) 
1049 (7) 
1114 (7) 
Excited state vibrational frequencies greater than ~ 
1200 cm were not measured. Excited state vibrational 
frequencies are dependent on X 
ex 
( 1 )  
( 2 )  
(3) 
X = 371.5 nm 
X®* = 369.6 nm 
X®^ = 368.6 nm 
ex 
(4) 
(5) 
( 6 )  
(7) 
367.2 nm 
365.8 nm 
364.3 nm 
362.9 nm 
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in the region of the vibronic sidebands of the + Sq 
electronic absorption band. All the fluorescence peaks 
correspond to (0-0) transitions, and the peaks follow the 
shift of the excitation frequency within the inhomogeneous 
band. The numbers (in cm ^) indicate the vibronic 
frequencies of the molecule in the excited electronic state 
(S^). Table 5 lists the ground and excited state 
vibrational frequencies, e.g., the fluorescence lines which 
are sufficiently intense to be useful in the identification 
of this adduct in a complex mixture. The detection limit 
for BPDE-globin can be expected to be comparable to that 
discussed above for BPDE-DNA. 
This example shows that FLNS is useful for the direct 
analysis of polar metabolites responsible for globin damage 
resulting from covalent binding of the same metabolites 
which damage DNA. This is significant because there appears 
to be a correlation between DNA damage and globin damage 
(94). Since a globin sample is far easier to obtain (than a 
DNA sample), the analysis of globin-adducts is an attractive 
alternative to the analysis of DNA-adducts. 
2. Metabolites in urine 
FLNS is also useful for the direct analysis of polar 
metabolites in urine. The analysis of mutagens in urine is 
generally complicated by several factors: urinary 
metabolites are usually present in low concentration and. 
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for fluorescence-based techniques, urine contains a variety 
of compounds which fluoresce. The selectivity and detection 
powers of FLNS and the possibility of time resolution 
should, in many cases, successfully overcome these 
difficulties, 
Figure 29 shows the FLN spectra of B[a]P tetrol in 
a 1:1 urine:pure glass mixture, "urine glass." The spectrum 
in Figure 29a was obtained using vibronic excitation and, 
therefore, the labeled peaks (in cm~^) correspond to excited 
state vibrations. The spectrum in Figure 29b was acquired 
with origin excitation and, therefore, its peaks correspond 
to ground-state vibrations. Comparison of the vibrational 
frequencies found in Figure 29b with those listed in Table 2 
for B[a]P tetrol in pure glass shows that there is a good 
agreement. 
For B[a]P tetrol in urine a ~ 1 picomole limit of 
detection has been obtained; further lowering of this limit 
is hampered by the presence of many other fluorescing 
compounds present in urine, which yield a relatively strong 
and broad background. A simple sample cleanup procedure 
could be used to remove these interfering compounds, 
resulting in a lower detection limit. Such a procedure 
would probably involve either an extraction with a nonpolar 
solvent or preconcentration on a disposable chromatographic 
column. 
Figure 29. FLN spectra of B[a]P tetrol in "urine glass" a) 
Spectrum obtained with (1-0) excitation (x^^ = 
369.6 nm). The labeled peaks correspond to 
excited state vibrational frequencies, in cm ^ 
b) Spectrum obtained with (0-0) excitation (X^^ 
= 377.1 nm). The labeled peaks correspond to 
ground state vibrational frequencies, in cm~^ 
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Other B[a]P metabolites, such as 7-HTHB[a]P, 
10-HTHB[a]P, B[a]P-diol and THB[a]P have been analyzed. In 
all these cases and many others (61-64,66,69,72-74) FLN 
spectra are obtainable, illustrating that FLNS is a widely 
applicable technique for the analysis of fluorescing 
compounds. Thus FLNS is a useful technique for monitoring a 
large number of environmental mutagens and carcinogens to 
which humans are exposed. Although the analysis of urinary 
metabolites does not provide a direct measure of the damage 
due to these compounds, it does provide a convenient 
indicator of human exposure since many mutagenic and 
carcinogenic metabolites and elimination products, e.g., 
detoxification and DNA adduct repair products, are excreted 
in urine. 
3. Real samples 
FLNS was successfully applied to the DNA isolated from 
fish exposed under controlled laboratory conditions to water 
contaminated with a mixture of dibenz[a,h]anthracene, 
benzo[b]fluoranthene and benzo[a]pyrene. The sample was 
expected to have a DNA damage level << 1:10^ from any single 
metabolite. Analysis by the Randerath (39,40) procedure had 
proven unsuccessful. Figure 30 shows the FLN spectrum, 
obtained under the conditions suitable for determination of 
the BPDE-DNA adduct resulting from a metabolite of 
benzo[a]pyrene. The fish FLN spectrum, however, does not 
Figure 30. FLN spectrum of fish DNA,.X - 369.6 nra 
(see discussion in text) 
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match the BPDE-DNA standard spectrum (compare Figs. 23 and 
30). Although a small contribution from the BPDE-DNA adduct 
is possible, FLN contributions from other species (as yet 
unidentified) dominate the spectrum. In addition it is 
possible that the BPDE metabolite can assume more than one 
binding conformation with DNA. The probability distribution 
function for binding could be affected by the mode of DNA 
exposure and other factors. It should be noted that the 
fluorescence spectra of the standard BPDE-DNA adduct and the 
fish DNA would be indistinguishable when obtained under 
non-line narrowing conditions. 
Further studies designed to characterize the species 
that are contributing to the fish DNA FLN spectrum were 
hampered by the unavailability of standard DNA adducts for 
the other two species involved. It is the author's belief 
that upon receipt and analysis of these standard adducts the 
specie or species responsible for the spectrum in Figure 30 
will be identified. 
4. Metabolic pathways 
Preliminary FLN results in the study of one electron 
oxidation as a metabolic pathway in the binding of B[a]P to 
DNA have been obtained. By this pathway, as described in 
the introduction, it is believed that B[a]P is oxidized to a 
radical cation at the 6 position which can bind to the 
slightly nucleophilic DNA. It is further postulated that 
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this binding mainly occurs at the N-7 and C-8 positions of 
guanine bases in the DNA chain. Following adduction the 
adducted bases are thought to depurinate, the N-7 bound 
adducts depurinating at a much faster rate than the C-8 
bound adducts (see Figure 8 and reference 32). These 
preliminary FLN experiments were concerned with detecting 
these depurination products in DNA samples exposed to B[a]P 
in the presence of horseradish peroxidase and HgOg (HRP-
DNA). The main depurination products expected are 
B[a]P-C-8dG, B [a]P-C-8gua, and B[a]P-N-7gua (32). For these 
studies, however, due to the rapid depurination rate of 
B[a]P-N-7gua and the necessary DNA cleanup procedure to 
remove excess B[a]P, the HRP-DNA samples are expected to 
contain only trace amounts of this base adduct. Samples of 
B[a]P-C-8dG, B[a]P-C-8G, B[a]P-C-8gua, B[a]P-N-7gua, 
6-MeB[a]P, and B[a]P were obtained and characterized at 
several excitation and observation wavelengths. Resolution 
of B[a]P, 6-MeB[a]P, and B[a]P-N-7gua from each other and 
the rest of the base adducts was trivial. The spectra 
obtained for B[a]P-C-8dG, B[a]P-C-8G, and B[a]P-C-8gua were 
very similar at the excitation wavelengths employed. This 
is not surprising when one notes that these base adducts are 
the depurination products from the same DNA adduct with only 
small structural differences, as shown in Figure 8. Figure 
31 shows the spectra of B[a]P-C-8gua, B[a]P, and two HRP-DNA 
Figure 31. FLN spectra of B[a]P-C-8gua, B[a]P, and two 
HRP-DNA samples, HRP-DNA (1) and HRP-DNA (3). 
The HRP-DNA (1) sample has undergone a more 
extensive cleanup procedure to remove excess 
B[a]P. See text 
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samples differing in the extent of post reaction cleanup, 
HRP-DNA having the more extensive cleanup. It is obvious 
that the HRP-DNA spectrum arises from the addition of the 
B[a]P and B[a]P-C-8gua spectra, while the HRP-DNA spectrum 
is missing the features associated with B[a]P. Due to the 
similarities of the three C-8 bound adducts it could not be 
conclusively determined which of these adducts are 
responsible for the features in the HRP-DNA spectrum. It 
should be emphasized that the data presented here are 
preliminary, further experiments are underway to resolve all 
of the adducts and identify the species present in the HRP 
DNA samples. The details and results of these and future 
experiments will be found in the thesis of Dan Zamzow, 
graduate student, Iowa State University. The important 
conclusion that should be drawn from these initial results 
is that FLNS is directly applicable to the investigation of 
metabolic pathways in chemical carcinogenesis. 
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IV. CONCLUSIONS 
The basic thrust of this research was to develop a 
prototype FLN system (69) into a highly selective and 
sensitive state of the art system for the detection and 
resolution of the PAH metabolites and adducts encountered in 
chemical carcinogenesis. 
The selectivity of FLNS was demonstrated by the 
successful resolution of separate mixtures of six polar PAH 
metabolites, five intact DNA adducts, each PAH metabolite 
and its corresponding DNA adduct, and finally six PAH 
metabolites and two DNA adducts. As employed for these 
complex mixtures, the selectivity is derived from the FLN 
phenomenon itself, selective excitation, time resolution, 
and vibronic excitation. 
To demonstrate the sensitivity of FLNS, the often-
studied BPDE-DNA adduct was used as a model. A detection 
g 
limit of ~ 3 modified bases in 10 was determined using 20 
pg of DNA, which corresponds to ~ 1 femtomole of adduct. In 
obtaining this detection limit for the bound metabolite at a 
spectral resolution of ~ 8 cm~^ it was necessary to 
eliminate the effects of photooxidation and NPHB which were 
both detrimental to the observed fluorescence intensity when 
the necessary high excitation power densities were employed. 
The elimination of photooxidation was trivial and was 
accomplished through the use of anaerobic sample conditions. 
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Circumventing the effects of NPHB was of a more challenging 
nature and required synchronous scanning of the laser and 
monochromator together with white light restoration pulses 
and higher sample temperatures. The first, synchronous 
scanning, was used to minimize radiation exposure of each 
isochromat and the last two were used to facilitate spectral 
diffusion/hole filling, all led to increased fluorescence 
intensity. 
The broad applicability of FLNS,in chemical 
carcinogenesis is demonstrated through its application to 
globin adducts, polar metabolites in urine, real samples, 
and the investigation of metabolic pathways. Moreover, FLN 
is operative for heme proteins (95) and photosynthetic 
antenna protein complexes (96). The point is that FLNS will 
be applicable to a wide range of biomolecules and 
biomolecular problems. 
In addition to being highly selective, highly sensitive, 
and versatile, FLN spectrometry is a practical technique. 
For a laser-based method the technology is simple 
(components available commercially) and the procedure for 
rapid sample cool-down (~ 2 minutes) insures a sample 
turnover rate that is high. Each spectrum presented here 
was acquired oh average in about 5 minutes. Thus, when the 
optimum excitation wavelengths for species of interest are 
known, dozens of samples can be analyzed during the course 
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of a day. At the same time, spectral features due to 
unknown components in a mixture would be identified. 
The introduction of this dissertation highlighted the 
characteristics of an "ideal" analytical method for the 
study of chemical carcinogenesis, and presented the most 
promising techniques. None of those presented possessed all 
of the desired characteristics. FLNS, however, most closely 
matched these requirements, its main limitation being the 
necessity of a fluorescing species of interest. This is not 
a great limitation in light of the fact that the two most 
potent classes of chemical carcinogens, Aflatoxins and PAH 
(97), are composed of strongly fluorescing compounds. 
To summarize, FLNS is a rapid, broadly applicable, 
highly sensitive, and highly selective analytical technique 
that can directly analyze carcinogenic metabolites and 
intact DNA adducts with minimal sample preparation. For 
these reasons FLNS should play an important part in the 
future investigation of chemical carcinogenesis. 
Future research with FLNS should include the continued 
investigation of one-electron oxidation as a metabolic route 
for the formation of PAH-DNA adducts. These studies should 
include the characterization of a large number of 
synthesized nucleoside and DNA adducts in order to build a 
spectral library of adducts. With this information the 
rapid identification of unknown adducts present in real 
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samples would be possible, yielding evidence of the 
metabolic process involved. 
FLNS studies to determine the relationship between 
carcinogenic exposure and metabolite levels in urine should 
also be pursued, along with similar studies involving globin 
adducts in blood. A successful outcome of these studies 
would establish FLNS as a suitable method for the routine 
monitoring of carcinogen exposure in the workplace. 
Finally, FLNS should be applied to the study of the 
aflatoxins. The aflatoxins are the most potent naturally 
occurring chemical carcinogens (98), and can be present in 
peanuts, peanut butter, milk and grain. Presently there is 
no adequate method for screening foods for these compounds. 
Initial experiments from this laboratory, not presented 
here, indicate that FLNS may be able to sensitively and 
selectively determine these compounds. If so, FLNS could be 
used to investigate aflatoxin DNA adduct metabolism, and it 
could also be employed as a method to screen foodstuffs for 
these deadly carcinogens. 
Clearly, FLNS has the potential to be an important 
analytical tool for the investigation of many biological 
applications. It is the author's opinion that the most 
exciting area of research with FLNS is its application to 
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the investigation of metabolic pathways in chemical 
carcinogenesis. It is this area which should, and 
undoubtedly will, receive the most attention in future work 
from this laboratory. 
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